false Q3 --01-31 2025 0001263364 Yes Yes 0001263364 2024-02-01 2024-10-31 0001263364 2024-12-11 0001263364 2024-10-31 0001263364 2024-01-31 0001263364 us-gaap:RelatedPartyMember 2024-10-31 0001263364 us-gaap:RelatedPartyMember 2024-01-31 0001263364 2024-08-01 2024-10-31 0001263364 2023-08-01 2023-10-31 0001263364 2023-02-01 2023-10-31 0001263364 us-gaap:PreferredStockMember 2023-01-31 0001263364 us-gaap:CommonStockMember 2023-01-31 0001263364 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001263364 COPR:SubscriptionReceivableMember 2023-01-31 0001263364 us-gaap:RetainedEarningsMember 2023-01-31 0001263364 2023-01-31 0001263364 us-gaap:PreferredStockMember 2023-04-30 0001263364 us-gaap:CommonStockMember 2023-04-30 0001263364 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001263364 COPR:SubscriptionReceivableMember 2023-04-30 0001263364 us-gaap:RetainedEarningsMember 2023-04-30 0001263364 2023-04-30 0001263364 us-gaap:PreferredStockMember 2023-07-31 0001263364 us-gaap:CommonStockMember 2023-07-31 0001263364 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0001263364 COPR:SubscriptionReceivableMember 2023-07-31 0001263364 us-gaap:RetainedEarningsMember 2023-07-31 0001263364 2023-07-31 0001263364 us-gaap:PreferredStockMember 2024-01-31 0001263364 us-gaap:CommonStockMember 2024-01-31 0001263364 us-gaap:AdditionalPaidInCapitalMember 2024-01-31 0001263364 COPR:SubscriptionReceivableMember 2024-01-31 0001263364 us-gaap:RetainedEarningsMember 2024-01-31 0001263364 us-gaap:AccountingStandardsUpdate202006Member us-gaap:PreferredStockMember 2024-01-31 0001263364 us-gaap:AccountingStandardsUpdate202006Member us-gaap:CommonStockMember 2024-01-31 0001263364 us-gaap:AccountingStandardsUpdate202006Member us-gaap:AdditionalPaidInCapitalMember 2024-01-31 0001263364 us-gaap:AccountingStandardsUpdate202006Member COPR:SubscriptionReceivableMember 2024-01-31 0001263364 us-gaap:AccountingStandardsUpdate202006Member us-gaap:RetainedEarningsMember 2024-01-31 0001263364 us-gaap:AccountingStandardsUpdate202006Member 2024-01-31 0001263364 us-gaap:PreferredStockMember 2024-04-30 0001263364 us-gaap:CommonStockMember 2024-04-30 0001263364 us-gaap:AdditionalPaidInCapitalMember 2024-04-30 0001263364 COPR:SubscriptionReceivableMember 2024-04-30 0001263364 us-gaap:RetainedEarningsMember 2024-04-30 0001263364 2024-04-30 0001263364 us-gaap:PreferredStockMember 2024-07-31 0001263364 us-gaap:CommonStockMember 2024-07-31 0001263364 us-gaap:AdditionalPaidInCapitalMember 2024-07-31 0001263364 COPR:SubscriptionReceivableMember 2024-07-31 0001263364 us-gaap:RetainedEarningsMember 2024-07-31 0001263364 2024-07-31 0001263364 us-gaap:PreferredStockMember 2023-02-01 2023-04-30 0001263364 us-gaap:CommonStockMember 2023-02-01 2023-04-30 0001263364 us-gaap:AdditionalPaidInCapitalMember 2023-02-01 2023-04-30 0001263364 COPR:SubscriptionReceivableMember 2023-02-01 2023-04-30 0001263364 us-gaap:RetainedEarningsMember 2023-02-01 2023-04-30 0001263364 2023-02-01 2023-04-30 0001263364 us-gaap:PreferredStockMember 2023-05-01 2023-07-31 0001263364 us-gaap:CommonStockMember 2023-05-01 2023-07-31 0001263364 us-gaap:AdditionalPaidInCapitalMember 2023-05-01 2023-07-31 0001263364 COPR:SubscriptionReceivableMember 2023-05-01 2023-07-31 0001263364 us-gaap:RetainedEarningsMember 2023-05-01 2023-07-31 0001263364 2023-05-01 2023-07-31 0001263364 us-gaap:PreferredStockMember 2023-08-01 2023-10-31 0001263364 us-gaap:CommonStockMember 2023-08-01 2023-10-31 0001263364 us-gaap:AdditionalPaidInCapitalMember 2023-08-01 2023-10-31 0001263364 COPR:SubscriptionReceivableMember 2023-08-01 2023-10-31 0001263364 us-gaap:RetainedEarningsMember 2023-08-01 2023-10-31 0001263364 us-gaap:PreferredStockMember 2024-02-01 2024-04-30 0001263364 us-gaap:CommonStockMember 2024-02-01 2024-04-30 0001263364 us-gaap:AdditionalPaidInCapitalMember 2024-02-01 2024-04-30 0001263364 COPR:SubscriptionReceivableMember 2024-02-01 2024-04-30 0001263364 us-gaap:RetainedEarningsMember 2024-02-01 2024-04-30 0001263364 2024-02-01 2024-04-30 0001263364 us-gaap:PreferredStockMember 2024-05-01 2024-07-31 0001263364 us-gaap:CommonStockMember 2024-05-01 2024-07-31 0001263364 us-gaap:AdditionalPaidInCapitalMember 2024-05-01 2024-07-31 0001263364 COPR:SubscriptionReceivableMember 2024-05-01 2024-07-31 0001263364 us-gaap:RetainedEarningsMember 2024-05-01 2024-07-31 0001263364 2024-05-01 2024-07-31 0001263364 us-gaap:PreferredStockMember 2024-08-01 2024-10-31 0001263364 us-gaap:CommonStockMember 2024-08-01 2024-10-31 0001263364 us-gaap:AdditionalPaidInCapitalMember 2024-08-01 2024-10-31 0001263364 COPR:SubscriptionReceivableMember 2024-08-01 2024-10-31 0001263364 us-gaap:RetainedEarningsMember 2024-08-01 2024-10-31 0001263364 us-gaap:PreferredStockMember 2023-10-31 0001263364 us-gaap:CommonStockMember 2023-10-31 0001263364 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0001263364 COPR:SubscriptionReceivableMember 2023-10-31 0001263364 us-gaap:RetainedEarningsMember 2023-10-31 0001263364 2023-10-31 0001263364 us-gaap:PreferredStockMember 2024-10-31 0001263364 us-gaap:CommonStockMember 2024-10-31 0001263364 us-gaap:AdditionalPaidInCapitalMember 2024-10-31 0001263364 COPR:SubscriptionReceivableMember 2024-10-31 0001263364 us-gaap:RetainedEarningsMember 2024-10-31 0001263364 COPR:PurchaseAgreementMember 2022-02-03 2022-02-03 0001263364 COPR:ShareExchangeAgreementMember 2023-01-23 2023-01-23 0001263364 us-gaap:ConvertibleDebtSecuritiesMember 2024-02-01 2024-10-31 0001263364 us-gaap:AccountingStandardsUpdate202006Member 2024-10-31 0001263364 COPR:SuretyAgreementMember 2016-12-31 0001263364 us-gaap:ConvertibleNotesPayableMember 2024-10-31 0001263364 us-gaap:ConvertibleNotesPayableMember 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember 2024-04-05 0001263364 us-gaap:ConvertibleNotesPayableMember 2024-04-05 2024-04-05 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:StevenRudofskyMember 2024-01-31 0001263364 COPR:StevenRudofskyMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:FeehanPartnersLPMember 2024-01-31 0001263364 COPR:FeehanPartnersLPMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:JeffreyVAndKarinRHembrockRevocableTrustMember 2024-01-31 0001263364 COPR:JeffreyVAndKarinRHembrockRevocableTrustMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:GaitondeLivingTrustGirishGaitondeTrusteeMember 2024-01-31 0001263364 COPR:GaitondeLivingTrustGirishGaitondeTrusteeMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:CoreyRedfieldMember 2024-01-31 0001263364 COPR:CoreyRedfieldMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:PVPartnersLPMember 2024-01-31 0001263364 COPR:PVPartnersLPMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:ShaunDykesMember 2024-01-31 0001263364 COPR:ShaunDykesMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:PatriciaCzerniejMember 2024-01-31 0001263364 COPR:PatriciaCzerniejMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:JamesDykesMember 2024-01-31 0001263364 COPR:JamesDykesMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:JasonCzerniejMember 2024-01-31 0001263364 COPR:JasonCzerniejMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:LouiseDykesMember 2024-01-31 0001263364 COPR:LouiseDykesMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:AndrewBrodkeyOneMember 2024-01-31 0001263364 COPR:AndrewBrodkeyOneMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:FeehanPartnersLPOneMember 2024-01-31 0001263364 COPR:FeehanPartnersLPOneMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:GilAtzmonMember 2024-01-31 0001263364 COPR:GilAtzmonMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember COPR:JonPowellMember 2024-01-31 0001263364 COPR:JonPowellMember us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 us-gaap:ConvertibleNotesPayableMember 2023-02-01 2024-01-31 0001263364 COPR:YinYinSilverLimitedMember 2024-10-31 0001263364 COPR:YinYinSilverLimitedMember 2024-02-01 2024-10-31 0001263364 COPR:YinYinSilverLimitedOneMember 2024-10-31 0001263364 COPR:YinYinSilverLimitedOneMember 2024-02-01 2024-10-31 0001263364 COPR:YinYinSilverLimitedTwoMember 2024-10-31 0001263364 COPR:YinYinSilverLimitedTwoMember 2024-02-01 2024-10-31 0001263364 COPR:BarrySwensonMember 2024-10-31 0001263364 COPR:BarrySwensonMember 2024-02-01 2024-10-31 0001263364 COPR:DonHAdairOrJoanneAdairMember 2024-10-31 0001263364 COPR:DonHAdairOrJoanneAdairMember 2024-02-01 2024-10-31 0001263364 COPR:JosephSwinfordOrDanielleSwinfordMember 2024-10-31 0001263364 COPR:JosephSwinfordOrDanielleSwinfordMember 2024-02-01 2024-10-31 0001263364 COPR:BrandonSwainOrSierraSwainMember 2024-10-31 0001263364 COPR:BrandonSwainOrSierraSwainMember 2024-02-01 2024-10-31 0001263364 COPR:ScottCollinsOrKendraCollinsMember 2024-10-31 0001263364 COPR:ScottCollinsOrKendraCollinsMember 2024-02-01 2024-10-31 0001263364 COPR:CarlCollinsOrEllenCollinsMember 2024-10-31 0001263364 COPR:CarlCollinsOrEllenCollinsMember 2024-02-01 2024-10-31 0001263364 COPR:JimHammerelMember 2024-10-31 0001263364 COPR:JimHammerelMember 2024-02-01 2024-10-31 0001263364 COPR:BretRenaudMember 2024-10-31 0001263364 COPR:BretRenaudMember 2024-02-01 2024-10-31 0001263364 COPR:ElatamGroupLtdMember 2024-10-31 0001263364 COPR:ElatamGroupLtdMember 2024-02-01 2024-10-31 0001263364 COPR:JamesHardyMember 2024-10-31 0001263364 COPR:JamesHardyMember 2024-02-01 2024-10-31 0001263364 COPR:AcepacHoldingsMember 2024-10-31 0001263364 COPR:AcepacHoldingsMember 2024-02-01 2024-10-31 0001263364 COPR:RickWardMember 2024-10-31 0001263364 COPR:RickWardMember 2024-02-01 2024-10-31 0001263364 COPR:RobertAndJoanSweetmanMember 2024-10-31 0001263364 COPR:RobertAndJoanSweetmanMember 2024-02-01 2024-10-31 0001263364 COPR:MichaelSwensonMember 2024-10-31 0001263364 COPR:MichaelSwensonMember 2024-02-01 2024-10-31 0001263364 COPR:ConnieSunMember 2024-10-31 0001263364 COPR:ConnieSunMember 2024-02-01 2024-10-31 0001263364 COPR:ElizabethEnochMember 2024-10-31 0001263364 COPR:ElizabethEnochMember 2024-02-01 2024-10-31 0001263364 COPR:WilliamCStantonAndCarolStantonMember 2024-10-31 0001263364 COPR:WilliamCStantonAndCarolStantonMember 2024-02-01 2024-10-31 0001263364 srt:OfficerMember 2024-02-01 2024-10-31 0001263364 COPR:StevenRudofskyMember us-gaap:ConvertibleNotesPayableMember 2023-01-23 0001263364 COPR:FeehanPartnersMember us-gaap:ConvertibleNotesPayableMember 2023-01-23 0001263364 COPR:FeehanPartnersMember COPR:ConvertibleNotesPayableOneMember 2023-01-23 0001263364 COPR:AndrewBrodkeyMember 2023-01-23 0001263364 COPR:ShaunDykesMember 2023-01-23 0001263364 COPR:StevenRudofskyMember 2024-04-05 0001263364 COPR:FeehanPartnersMember 2024-04-05 0001263364 COPR:AndrewBrodkeyMember 2024-04-05 0001263364 COPR:ShaunDykesMember 2024-04-05 0001263364 COPR:StevenRudofskyMember 2024-04-05 2024-04-05 0001263364 COPR:FeehanPartnersMember 2024-04-05 2024-04-05 0001263364 COPR:AndrewBrodkeyMember 2024-04-05 2024-04-05 0001263364 COPR:ShaunDykesMember 2024-04-05 2024-04-05 0001263364 COPR:RobertScannellMember 2024-04-03 2024-04-03 0001263364 2024-04-03 2024-04-03 0001263364 us-gaap:CommonStockMember 2024-04-03 2024-04-03 0001263364 COPR:FeehanPartnersMember us-gaap:WarrantMember 2024-04-04 2024-04-04 0001263364 COPR:AndrewBrodkeyMember us-gaap:WarrantMember 2024-04-04 2024-04-04 0001263364 COPR:FeehanPartnersMember us-gaap:CommonStockMember 2024-04-04 2024-04-04 0001263364 COPR:AndrewBrodkeyMember us-gaap:CommonStockMember 2024-04-04 2024-04-04 0001263364 COPR:ShaunDykesMember us-gaap:WarrantMember 2024-04-06 2024-04-06 0001263364 COPR:ShaunDykesMember us-gaap:CommonStockMember 2024-04-06 2024-04-06 0001263364 COPR:StevenRudofskyMember us-gaap:WarrantMember 2024-04-08 2024-04-08 0001263364 COPR:StevenRudofskyMember us-gaap:CommonStockMember 2024-04-08 2024-04-08 0001263364 COPR:StevenRudofskyMember 2024-05-01 2024-05-01 0001263364 COPR:AndrewBrodkeyMember 2024-05-01 2024-05-01 0001263364 COPR:RobertScannellMember 2024-05-01 2024-05-01 0001263364 COPR:AndrewBrodkeyMember 2024-08-02 2024-08-02 0001263364 COPR:StevenRudofskyMember 2024-08-02 2024-08-02 0001263364 COPR:RobertScannellMember 2024-08-02 2024-08-02 0001263364 COPR:AndrewBrodkeyMember 2024-09-25 2024-09-25 0001263364 COPR:RobertScannellMember 2024-09-25 2024-09-25 0001263364 COPR:StevenRudofskyMember 2024-09-25 2024-09-25 0001263364 COPR:AndrewBrodkeyMember 2024-10-31 0001263364 COPR:SubscriptionAgreementMember 2024-01-12 2024-01-12 0001263364 COPR:SubscriptionAgreementMember us-gaap:CommonStockMember 2024-01-12 2024-01-12 0001263364 COPR:SubscriptionAgreementMember 2024-01-12 0001263364 us-gaap:WarrantMember COPR:SubscriptionAgreementMember 2024-01-12 0001263364 us-gaap:WarrantMember 2024-02-01 2024-10-31 0001263364 COPR:SubscriptionAgreementMember 2024-10-31 0001263364 COPR:SubscriptionAgreementMember 2024-02-01 2024-10-31 0001263364 srt:OfficerMember 2024-05-31 2024-05-31 0001263364 COPR:OtherEmployeesAndNonEmployeesMember 2024-08-02 2024-08-02 0001263364 COPR:EmployeesAndNonEmployeesMember 2024-09-25 2024-09-25 0001263364 COPR:NonOfficerMember 2024-02-01 2024-10-31 0001263364 COPR:OfficersDirectorsAndEmployeesMember 2023-01-23 2023-01-23 0001263364 2023-02-01 2024-01-31 0001263364 2023-01-23 0001263364 2023-01-23 2023-01-23 0001263364 COPR:AndrewBrodkeyMember 2024-04-03 2024-04-03 0001263364 COPR:StevenRudofskyMember 2024-04-03 2024-04-03 0001263364 COPR:ShaunDykesMember 2024-04-03 2024-04-03 0001263364 us-gaap:WarrantMember 2024-04-06 2024-04-06 0001263364 us-gaap:CommonStockMember 2024-04-06 2024-04-06 0001263364 COPR:JanuaryTwentyThreeTwentyTwentyThreeMember 2024-10-31 0001263364 COPR:MayEightTwentyTwentyThreeMember 2024-10-31 0001263364 us-gaap:MeasurementInputSharePriceMember us-gaap:WarrantMember srt:MinimumMember 2024-10-31 0001263364 us-gaap:MeasurementInputSharePriceMember us-gaap:WarrantMember srt:MaximumMember 2024-10-31 0001263364 us-gaap:MeasurementInputExercisePriceMember us-gaap:WarrantMember 2024-10-31 0001263364 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember srt:MinimumMember 2024-10-31 0001263364 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember srt:MaximumMember 2024-10-31 0001263364 us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2024-10-31 0001263364 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember srt:MinimumMember 2024-10-31 0001263364 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember srt:MaximumMember 2024-10-31 0001263364 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:WarrantMember 2024-10-31 0001263364 COPR:LongTermLeaseAgreementMember 2024-04-01 2024-04-01 0001263364 COPR:LongTermLeaseAgreementMember 2024-04-01 0001263364 COPR:LongTermLeaseAgreementMember 2024-10-31 0001263364 2024-03-05 2024-03-05 0001263364 COPR:LongTermLeaseAgreementMember srt:ScenarioForecastMember 2024-05-01 2025-02-01 0001263364 COPR:SecuredPromissoryNoteMember us-gaap:SubsequentEventMember 2024-11-04 0001263364 us-gaap:SubsequentEventMember 2024-11-04 0001263364 COPR:AndrewBrodkeyMember us-gaap:SubsequentEventMember 2024-11-05 2024-11-05 0001263364 COPR:StevenRudofskyMember us-gaap:SubsequentEventMember 2024-11-05 2024-11-05 0001263364 us-gaap:CommonStockMember COPR:AndrewBrodkeyMember 2024-11-05 2024-11-05 0001263364 us-gaap:CommonStockMember COPR:StevenRudofskyMember 2024-11-05 2024-11-05 0001263364 us-gaap:CommonStockMember COPR:OtherEmployeesAndNonEmployeesMember us-gaap:SubsequentEventMember 2024-11-05 2024-11-05 0001263364 us-gaap:SubsequentEventMember COPR:StevenRudofskyMember 2024-11-05 0001263364 COPR:StevenRudofskyMember us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2024-11-05 2024-11-05 0001263364 us-gaap:CommonStockMember 2024-07-11 2024-07-11 0001263364 COPR:SeriesAConvertibleNonVotingPreferredStockMember us-gaap:PrivatePlacementMember 2024-07-11 2024-07-11 0001263364 COPR:SeriesAConvertibleNonVotingPreferredStockMember us-gaap:PrivatePlacementMember 2024-07-11 0001263364 us-gaap:WarrantMember 2024-07-11 0001263364 COPR:PlacementAgentMember 2024-07-11 2024-07-11 0001263364 COPR:FormerShareholdersMember 2023-01-23 2023-01-23 0001263364 2022-12-15 2022-12-15 0001263364 2024-04-05 2024-04-05 0001263364 2024-04-05 0001263364 COPR:ConsultantsMember 2024-07-11 2024-07-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

Quarterly report pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

For the quarterly period ended October 31, 2024

 

Transition report pursuant to Section 13 or 15(d) of the Exchange Act

 

For the transition period from _________ to _________.

 

 

IDAHO COPPER CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

Nevada   333-108715   98-0221494
(State or Other Jurisdiction   (Commission   (I.R.S. Employer
of Incorporation)   File Number)   Identification No.)

 

800 W. Main Street, Suite 1460, Boise, ID 83702

(Address of Principal Executive Offices)

 

(208) 274-9220

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common   COPR   OTC

 

Securities registered pursuant to Section 12(g) of the Act:

 

N/A

(Title of class)

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐

 

Note: The Registrant has voluntarily filed all periodic reports under the Securities Exchange Act of 1934 for the preceding 12 months.

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

(Check One):

 

Large Accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Regulation 12b-2 of the Exchange Act): YES ☐ NO

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of December 11, 2024, the issuer had 256,942,937 shares issued, issuable, and outstanding.

 

 

 

 

 

 

IDAHO COPPER CORPORATION

 

QUARTERLY REPORT ON FORM 10-Q

 

October 31, 2024

 

TABLE OF CONTENTS

 

    Page
PART I. FINANCIAL INFORMATION 3
     
Item 1. Condensed Consolidated Financial Statements (unaudited) 3
  Condensed Consolidated Balance Sheets (unaudited) 4
  Condensed Consolidated Statements of Operations (unaudited) 5
  Condensed Consolidated Statements of Changes in Stockholders’ Deficit (unaudited) 6
  Condensed Consolidated Statements of Cash Flows (unaudited) 7
  Notes to the Condensed Consolidated Financial Statements (unaudited) 8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 17
Item 3. Quantitative and Qualitative Disclosures about Market Risk 19
Item 4. Controls and Procedures 19
     
PART II. OTHER INFORMATION 20
     
Item 1. Legal Proceedings 20
Item 1A. Risk Factors 20
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 20
Item 3. Defaults Upon Senior Securities 20
Item 4. Mine Safety Disclosures 20
Item 5. Other Information 20
Item 6. Exhibits 21
  Signatures 22

 

 

 

 

FORWARD LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that involve substantial risks and uncertainties. Forward-looking statements include statements preceded by, followed by or that include the words “may,” “could,” “would,” “should,” “believe,” “expect,” “anticipate,” “plan,” “estimate,” “target,” “project,” “intend” and similar words or expressions. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements. Investors should carefully consider all of such risks before making an investment decision with respect to the Company’s stock. The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements for Idaho Copper Corporation. Any forward-looking statement made by us in this Form 10Q is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

 

2

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1 - CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

IDAHO COPPER CORPORATION

(UNAUDITED)

 

Contents

 

  Page
Condensed Consolidated Financial Statements (unaudited)  
Condensed Consolidated Balance Sheets as of October 31, 2024, and January 31, 2024 (unaudited) 4
Condensed Consolidated Statements of Operations for the three and nine months ended October 31, 2024, and 2023 (unaudited) 5
Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the three and nine months ended October 31, 2024, and 2023 (unaudited) 6
Condensed Consolidated Statements of Cash Flows for the nine months ended October 31, 2024, and 2023 (unaudited) 7
Notes to the Condensed Consolidated Financial Statements (unaudited) 8-16

 

3

 

 

IDAHO COPPER CORPORATION

Condensed Consolidated Balance Sheets

(unaudited)

 

   October 31,   January 31, 
   2024   2024 
ASSETS          
Current assets          
Cash  $18,731   $30,146 
Prepaid expenses   134,716    21,624 
Total current assets   153,447    51,770 
           
Right of use asset   20,843    - 
Deposit   100,000    100,000 
           
Total assets  $274,290   $151,770 
           
CURRENT LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities          
Accounts payable and accrued expenses  $385,958   $434,519 
Accrued expenses to related parties   388,971    370,135 
Accrued interest, current portion   284,279    1,115,723 
Note payable   25,000    - 
Lease liability   20,843    - 
Bond liabilities, current portion   546,000    - 
Total current liabilities   1,651,051    1,920,377 
Non-current liabilities          
Bond liabilities, non-current portion   2,589,000    3,135,000 
Convertible notes payable, net of discounts   -    623,999 
Accrued interest, non-current portion   1,590,724    533,003 
Total non-current liabilities   4,179,724    4,292,002 
Total liabilities   5,830,775    6,212,379 
           
Commitments and contingencies (Note 8)   -    - 
           
Stockholders’ deficit          
Preferred stock, $0.001 par value, 10,000,000 shares authorized, 186.67 and 23 shares issued and outstanding at October 31, 2024 and January 31, 2024, respectively   -    - 
Common stock, $0.001 par value, 500,000,000 shares authorized, 256,942,937 and 214,647,732 shares issued and outstanding at October 31, 2024 and January 31, 2024, respectively   256,943    214,648 
Additional paid-in capital   30,625,010    25,336,048 
Subscription receivable   -    (11,000)
Accumulated deficit   (36,438,438)   (31,600,305)
Total stockholders’ deficit   (5,556,485)   (6,060,609)
           
Total liabilities and stockholders’ deficit  $274,290   $151,770 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

4

 

 

IDAHO COPPER CORPORATION

Condensed Consolidated Statements of Operations

(unaudited)

 

   2024   2023   2024   2023 
   Three Months Ended   For the Nine Months Ended 
   October 31,   October 31, 
   2024   2023   2024   2023 
Revenue  $-   $-   $-   $- 
                     
Operating expenses                    
Professional fees   285,336    100,821    625,945    357,622 
Payroll and related expenses   60,000    282,500    512,650    639,500 
Rent expense   28,800    10,500    171,885    31,500 
Stock-based compensation   1,704,024    -    2,258,080    140,739 
Other general and administrative expenses   126,808    42,905    554,830    67,459 
Total operating expenses   2,204,968    436,726    4,123,390    1,236,820 
                     
Operating loss   (2,204,968)   (436,726)   (4,123,390)   (1,236,820)
                     
Other income (expense)                    
Amortization of beneficial conversion feature   -    (68,566)   -    (203,812)
Amortization of debt discount   -    (11,316)   (19,490)   (22,633)
Interest income   440    -    6,846    - 
Interest expense   (148,053)   (63,851)   (296,795)   (279,725)
Total other income (expense)   (147,613)   (143,733)   (309,439)   (506,170)
                     
Net loss  $(2,352,581)  $(580,459)  $(4,432,829)  $(1,742,990)
                     
Basic and diluted net loss per common share  $(0.01)  $(0.00)  $(0.02)  $(0.01)
Basic and diluted weighted average common shares outstanding   253,460,307    210,365,353    242,282,623    210,175,251 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

5

 

 

IDAHO COPPER CORPORATION

Condensed Consolidated Statements of Changes in Stockholders’ Deficit

For the Nine Months Ended October 31, 2024 and 2023

(unaudited)

 

   Shares   Amount   Shares   Amount   Capital   Receivable   Deficit   Total 
                   Additional       Accumu-     
   Preferred Stock   Common Stock   Paid-in   Subscription   lated     
   Shares   Amount   Shares   Amount   Capital   Receivable   Deficit   Total 
Balance, January 31, 2023   -   $-    208,457,823   $208,458   $23,059,223   $-   $(27,888,258)  $(4,620,577)
Common stock options issued for services   -    -    879,628    879    139,860    -    -    140,739 
Net loss for the period ended April 30, 2023   -    -    -    -    -    -    (575,001)   (575,001)
Balance, April 30, 2023   -   $-    209,337,451   $209,337   $23,199,083   $-   $(28,463,259)  $(5,054,839)
Warrants issued   -    -    -    -    103,846    -    -    103,846 
Net loss for the period ended July 31, 2023   -    -    -    -    -    -    (587,531)   (587,531)
Balance, July 31, 2023   -   $-    209,337,451   $209,337   $23,302,929   $-   $(29,050,790)  $(5,538,524)
Conversion of liabilities to common stock   -    -    3,844,073    3,845    265,240    -    -    269,085 
Net loss for the period ended October 31, 2023   -    -    -    -    -    -    (580,459)   (580,459)
Balance, October 31, 2023   -   $-    213,181,524   $213,182   $23,568,169   $-   $(29,631,249)  $(5,849,898)
                                         
Balance, January 31, 2024   23   $-    214,647,732   $214,648   $25,336,048   $(11,000)  $(31,600,305)  $(6,060,609)
Adoption of ASU 2020-06   -    -    -    -    -    -    (405,305)   (405,305)
Sale of preferred stock   139    -    -    -    1,742,300    11,000    -    1,753,300 
Conversion of convertible notes payable   -    -    12,848,116    12,848    1,035,945    -    -    1,048,793 
Exercise of warrants   -    -    4,781,249    4,781    (4,781)   -    -    - 
Exercise of options   -    -    14,740,000    14,740    (14,740)   -    -    - 
Stock based compensation   -    -    -    -    189,248    -    -    189,248 
Net loss for the period ended April 30, 2024   -    -    -    -    -    -    (1,044,266)   (1,044,266)
Balance, April 30, 2024   162   $-    247,017,097   $247,017   $28,284,020   $-   $(33,049,876)  $(4,518,839)
Exercise of options   -    -    -    -    -    -    -    - 
Sale of preferred stock   23.67    -    -    -    320,084    -    -    320,084 
Stock based compensation   -    -    1,888,173    1,888    362,920    -    -    364,808 
Exercise of warrant   -    -    1,041,667    1,042    (1,042)   -    -    - 
Costs related to sale of preferred stock   -    -    -    -    (50,000)   -    -    (50,000)
Net loss for the period ended July 31, 2024   -    -    -    -    -    -    (1,035,981)   (1,035,981)
Balance, July 31, 2024   185.67   $-    249,946,937   $249,947   $28,915,982   $-   $(34,085,857)  $(4,919,928)
Sale of preferred stock   1    -    -    -    12,000    -    -    12,000 
Stock-based compensation   -    -    6,996,000    6,996    1,697,028    -    -    1,704,024 
Net loss for the period ended October 31, 2024   -    -    -    -    -    -    (2,352,581)   (2,352,581)
Balance, October 31, 2024   186.67   $-    256,942,937   $256,943   $30,625,010   $-   $(36,438,438)  $(5,556,485)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

6

 

 

IDAHO COPPER CORPORATION

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended October 31,

(unaudited)

 

   2024   2023 
Cash flows from operating activities:          
Net loss  $(4,432,829)  $(1,742,990)
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock-based compensation   2,258,080    140,739 
Amortization of beneficial conversion feature   -    203,812 
Amortization of debt discount   19,490    22,633 
Change in assets and liabilities:          
Prepaid expenses   (113,092)   (24,472)
Accounts payable and accrued expenses   (52,400)   123,032 
Accrued expenses - related party   22,676    481,387 
Accrued interest   226,276    180,999 
Net cash used in operating activities   (2,071,799)   (614,860)
           
Cash flows from financing activities:          
Proceeds from convertible notes payable   -    201,200 
Proceeds from note payable   25,000    - 
Proceeds from sale of preferred stock   2,035,384    - 
Net cash provided by financing activities   2,060,384    201,200 
           
Net decrease in cash   (11,415)   (413,660)
           
Cash at beginning of period   30,146    431,374 
           
Cash at end of period  $18,731   $17,714 
           
Cash paid for interest  $-   $- 
Cash paid for taxes  $-   $- 
           
Non-cash investing and financing activities:          
Conversion of convertible notes payable  $1,048,793   $269,085 
Cashless exercise of warrants and options  $20,563   $- 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

7

 

 

IDAHO COPPER CORPORATION

and Subsidiaries

Notes to the Condensed Consolidated Financial Statements

October 31, 2024

(unaudited)

 

NOTE 1 – NATURE OF OPERATIONS

 

The accompanying condensed consolidated financial statements include the financial statements of Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.) (referred to herein as “Idaho Copper”). Idaho Copper is hereinafter referred to as the “Company,” “we” and “us.”

 

On February 3, 2022, the Company consummated the transactions contemplated by the Stock Purchase Agreement dated as of January 31, 2022 (the “Purchase Agreement”), by and among the Company, Crystal Globe Limited, a company incorporated under the laws of British Virgin Islands (the “Seller”), and JHP Holdings, Inc., a Nevada corporation (the “Buyer”), pursuant to which the Buyer purchased 16,644,820 shares of common stock of the Company from the Seller.

 

On January 23, 2023, the Company entered into and consummated the transactions contemplated by a share exchange agreement (the “Share Exchange Agreement”) by and among the Company, International CuMo Mining Corporation, an Idaho corporation (“ICUMO”), and all of the shareholders of ICUMO (collectively, the “ICUMO Shareholders”). Pursuant to the terms of the Share Exchange Agreement (the “RTO”), the ICUMO Shareholders transferred all the issued and outstanding shares of common stock of ICUMO to the Company in exchange for 182,240,000 shares of the Company’s common stock, par value $0.001 per share. As a result of this share exchange (the “Exchange”), ICUMO became a wholly owned subsidiary of the Company. See Note 7. For financial reporting purposes, the acquisition of ICUMO and the change of control in connection with the acquisition represented a “reverse merger” and ICUMO is deemed to be the accounting acquirer in the transaction. ICUMO is the acquirer for financial reporting purposes, and the Company is the acquired company. Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the acquisition are those of ICUMO.

 

The Company continues to be a “smaller reporting company,” as defined under the Exchange Act of 1934, as amended (the “Exchange Act”) following the Exchange, however, as a result of the Exchange, the Company has ceased to be a “shell company” (as such term is defined in Rule 12b-2 under the Exchange Act).

 

ICUMO Background

 

ICUMO is an exploration and development company with mineral right interests in the United States of America. ICUMO was originally incorporated under the laws of Nevada in 2005, as Mosquito Mining Corp. In 2013, the Company was moved to Idaho and the name changed to Idaho CuMo Mining Corporation. In early February 2023 the name was changed to Idaho Copper Corporation.

 

Nature of Operations

 

The Company is in the process of exploring its mineral rights interests in the United States and as of the date of these condensed consolidated financial statements, has not yet determined whether any of its mineral properties contain economically recoverable mineral reserves. Accordingly, the carrying amount of mineral right interests represents cumulative expenditures incurred to date and does not necessarily reflect present or future values. The recovery of these costs is dependent upon the discovery of economically recoverable mineral reserves and the ability of the Company to obtain the necessary financing to complete their exploration and development and to resolve any environmental, regulatory, or other constraints. Uncertainty also exists with respect to the recoverability of the carrying value of certain mineral rights interests. The ability of the Company to realize its investment in resource properties is contingent upon the resolution of the uncertainties and confirmation of the Company’s title to the mineral properties.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The Company follows the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (“US GAAP”) and has a year-end of January 31. On March 9, 2023, the Company filed with the State of Nevada for a year-end change from December 31 to January 31. The condensed consolidated financial statements are based on the balance sheets and statements of operations of ICUMO on a post-merger basis.

 

The unaudited condensed consolidated financial statements of the Company for the nine-month periods ended October 31, 2024, and 2023 have been prepared in accordance with US GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. Accordingly, they do not include all the information and footnotes required by US GAAP for complete financial statements. However, such information reflects all adjustments (consisting solely of normal recurring adjustments unless otherwise indicated), which are, in the opinion of management, necessary for the fair presentation of the financial position and the results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full fiscal year. The condensed consolidated balance sheet information as of January 31, 2024, was derived from the audited financial statements included in the Company’s financial statements as of and for the year ended January 31, 2024, included as an exhibit to the Company’s Quarterly Report on Form 10-Q for the period ended October 31, 2024, as filed with the Securities and Exchange Commission (the “SEC”). These condensed consolidated financial statements should be read in conjunction with that report.

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in the consolidation. The condensed consolidated financial statements included herein, are presented in accordance with US GAAP, and stated in United States dollars, and have been prepared by the Company, pursuant to the rules and regulations of the SEC.

 

8

 

 

Liquidity and Going Concern

 

We have incurred recurring losses since inception and expect to continue to incur losses as a result of legal and professional fees and our corporate general and administrative expenses. On October 31, 2024, we had $18,731 in cash. Our net loss incurred for the nine months ended October 31, 2024, was $4,432,829 and the working capital deficit was $1,497,605 on October 31, 2024. As a result, there is substantial doubt about our ability to continue as a going concern. In the event that we are unable to generate sufficient cash from our operating activities or raise additional funds, we may be required to delay, reduce or severely curtail our operations or otherwise impede our on-going business efforts, which could have a material adverse effect on our business, operating results, financial condition and long-term prospects. The Company expects to seek to obtain additional funding through increased revenues and future financing. There can be no assurance as to the availability or terms upon which such financing and capital might be available. The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern.

 

Use of Estimates

 

The preparation of condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash

 

Cash is comprised of cash balances. Cash is held at major financial institutions and is subject to credit risk to the extent that those balances exceed applicable Federal Deposit Insurance Corporation (“FDIC”) insurance amounts of $250,000. From time to time, the Company has certain cash balances, including restricted cash, that may exceed insured limits. The Company utilizes large and reputable banking institutions which it believes mitigates these risks. The Company has not experienced any losses in such accounts. As of October 31, 2024, the Company’s cash balance did not exceed the insurance limits.

 

Stock-Based Compensation

 

The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718, Compensation – Stock Compensation, and Certain Redeemable Financial Instruments. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method.

 

Fair Value of Financial Instruments

 

The book values of cash and accounts payable approximate their respective fair values due to the short-term nature of these instruments. The fair value hierarchy under US GAAP distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs).

 

The hierarchy consists of three levels

 

  Level one — Quoted market prices in active markets for identical assets or liabilities;
  Level two — Inputs other than level one inputs that are either directly or indirectly observable; and
  Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

 

Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter.

 

Net Loss Per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by FASB, ASC Topic 260, Earnings per Share. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. The Company has 53,214,479 dilutive shares (related to the convertible notes (see Note 4)) of common stock as of October 31, 2024.

 

Income Taxes

 

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and loss carryforwards and their respective tax bases.

 

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income (loss) in the years in which those temporary differences are expected to be recovered or settled.

 

The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

 

Tax benefits of uncertain tax positions are recognized only if it is more likely than not that the Company will be able to sustain a position taken on an income tax return. The Company has no liability for uncertain tax positions as of October 31, 2024. Interest and penalties, if any, related to unrecognized tax benefits would be recognized as interest expense. The Company does not have any accrued interest or penalties associated with unrecognized tax benefits, nor was any significant interest expense recognized during the nine months ended October 31, 2024.

 

9

 

 

Recently Issued and Adopted Accounting Pronouncements

 

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for convertible Instruments and Contracts in an Entity’s Own Equity, to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity. This ASU significantly changes the guidance on the issuer’s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity’s own equity so that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants which require liability treatment. ASU 2020-06 is effective for smaller reporting companies for fiscal years beginning after December 15, 2023. The Company adopted this standard on February 1, 2024. As a result, the Company derecognized $405,305 for the remaining balance of the unamortized beneficial conversion features attributable to its outstanding convertible notes payable. The Company elected to use the modified retrospective approach as of the adoption date and recognized an adjustment to the opening balance of its accumulated deficit in the amount of $405,305.

 

Convertible Debentures

 

The Company presents convertible debentures separately in its debt and equity components within the balance sheet. The fair value of a compound instrument at issuance is assigned to its respective debt and equity components. The fair value of the debt component is established first with the equity component being determined by the residual amount.

 

The Company measures the cost of equity-settled transactions with employees by reference to the fair value of the equity instruments at the date in which they are granted. Estimating fair values for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant.

 

The fair value of the Company’s stock option and warrant grants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expenses are recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

 

Unproven Mineral Right Interests

 

The Company will capitalize into intangible assets all costs, net of any recoveries, of acquiring, exploring, and evaluating an unproven mineral right interest, until the rights to which they relate are placed into production, at which time these deferred costs will be amortized over the estimated useful life of the rights upon commissioning the property, or written-off if the rights are disposed of, impaired or abandoned, when applicable.

 

Management reviews the carrying amounts of mineral rights annually or when there are indicators of impairment and will recognize impairment based upon current exploration results and upon assessment of the probability of profitable exploitation of the rights. An indication of impairment includes but is not limited to expiration of the right to explore, substantive expenditure in the specific area is neither budgeted nor planned, and if the entity has decided to discontinue exploration activity in a specific area. Management’s assessment of the mineral right’s fair value is also based upon a review of other mineral right transactions that have occurred in the same geographic area as that of the rights under review.

 

Costs will include the cash consideration and the fair value of shares issued on the acquisition of mineral rights. Rights acquired under option or joint venture agreements, whereby payments are made at the sole discretion of the Company, are not accrued and are only recorded in the accounts when the payments are made. Proceeds from property option payments received by the Company are netted against the deferred costs of the related mineral rights, with any excess being included in operations.

 

The application of the Company’s accounting policy for unproven mineral right interests requires judgment in determining whether it is likely that future economic benefits will flow to the Company, which may be based on assumptions about future events or circumstances. Estimates and assumptions may change if new information becomes available. If, after expenditures are capitalized, information becomes available suggesting that the recovery of the expenditures is unlikely, the amount capitalized is impaired with a corresponding charge to profit or loss in the period in which the new information becomes available.

 

There may be material uncertainties associated with the Company’s title and ownership of its unproven mineral right interests. Ordinarily the Company does not own the land upon which an interest is located, and title may be subject to unregistered prior agreements or transfers or other undetected defects.

 

Impairment of Long-Lived Assets

 

The Company’s future long-lived assets and other assets (consisting of property and equipment) will be reviewed for impairment in accordance with the guidance of the FASB ASC Topic 360-10, Property, Plant, and Equipment. Long lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used are measured by a comparison of the carrying amount of an asset to the undiscounted future net cash flows expected to be generated by that asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.

 

Reclamation Provision

 

An obligation to incur restoration, rehabilitation and environmental costs arises when environmental disturbance is caused by the exploration, development, or ongoing production of a mineral property interest. Such costs arising from the decommissioning of plant and other site preparation work, discounted to their net present value, are provided and capitalized at the start of each project to the carrying amount of the asset, as soon as the obligation to incur such costs arises. Discount rates using a pre-tax rate that reflect the time value of money are used to calculate the net present value. These costs are charged against profit or loss over the economic life of the related asset, through amortization using either the unit-of-production or straight-line method. The related liability is adjusted for each period for the unwinding of the discount rate and for changes to the current market-based discount rate, amount or timing of the underlying cash flows needed to settle the obligation. Costs for restoration of subsequent site damage which is created on an ongoing basis during production are provided for at their net present values and charged against profits as extraction progresses. As of October 31, 2024, there are no costs as production has not yet commenced.

 

 

Related Party Transactions

 

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or significant common influence, related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. Related party transactions that are in the normal course of business and have commercial substance are measured at the exchange amount, which is determined on a cost recovery basis.

 

10

 

 

Stock Purchase Warrants

 

The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity. We determine the accounting classification of warrants we issue, as either liability or equity classified, by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity, then in accordance with ASC 815-40, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock. Under ASC 480, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate us to settle the warrants or the underlying shares by paying cash or other assets, and warrants that must or may require settlement by issuing variable number of shares. If warrants do not meet the liability classification under ASC 480-10, we assess the requirements under ASC 815-40, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature.

 

If the warrants do not require liability classification under ASC 815-40, in order to conclude equity classification, we also assess whether the warrants are indexed to our common stock and whether the warrants are classified as equity under ASC 815-40 or other US GAAP. After all such assessments, we conclude whether the warrants are classified as liability or equity. Liability classified warrants require fair value accounting at issuance and subsequent to initial issuance with all changes in fair value after the issuance date recorded in the statements of operations. Equity classified warrants only require fair value accounting at issuance with no changes recognized subsequent to the issuance date.

 

NOTE 3 – RECLAMATION BONDS AND PROVISIONS

 

Reclamation Bonds and Provisions

 

During 2016, the Company entered into a surety agreement that guarantees the reclamation bond on the CuMo Property. In order to maintain the good standing of this surety, the Company is required to make an annual payment of $8,340. The Company has a deposit of $100,000 (as reflected in Deposit on the balance sheet) for the reclamation bond which has a face value of $278,000 as determined by the United States Department of Agriculture Forest Service.

 

The security deposit is refundable when the Company completes the required reclamation clean-up costs.

 

 

NOTE 4 – CONVERTIBLE NOTES

 

The Company has $0 and $1,100,200 in convertible secured notes payable at October 31, 2024, and January 31, 2024. The balances as of January 31, 2024 were as follows:

 

          Issue  Maturity  Conversion   Conversion   Warrants   Exercise   Warrant
   Balance   Collateral  Date  Date  Price   Shares   Shares   Price   Expiration
Steven Rudofsky  $125,000   (a)  1/23/23  7/23/25  $0.10    1,250,000    1,250,000   $0.15   1/23/28
Feehan Partners, LP  $87,334   (a)  1/23/23  7/23/25  $0.10    873,340    873,340   $0.15   1/23/28
The Jeffrey V. and Karin R. Hembrock Revocable Trust  $100,000   (a)  1/23/23  7/23/25  $0.10    1,000,000    1,000,000   $0.15   1/23/28
The Gaitonde Living Trust, Girish Gaitonde Trustee  $100,000   (a)  1/23/23  7/23/25  $0.10    1,000,000    1,000,000   $0.15   1/23/28
Corey Redfield  $50,000   (a)  1/23/23  7/23/25  $0.10    500,000    500,000   $0.15   1/23/28
PV Partners, LP  $75,000   (a)  1/23/23  7/23/25  $0.10    750,000    750,000   $0.15   1/23/28
Shaun Dykes  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Patricia Czerniej  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
James Dykes  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Jason Czerniej  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Louise Dykes  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Andrew Brodkey  $98,000   (a)  1/23/23  7/23/25  $0.10    980,000    980,000   $0.15   1/23/28
Feehan Partners, LP  $112,666   (a)  1/23/23  7/23/25  $0.10    1,126,660    1,126,660   $0.15   1/23/28
Gil Atzmon  $102,200   (a)  5/8/23  11/8/25  $0.23    440,000    550,000   $0.23   5/8/26
Jon Powell  $100,000   (a)  5/8/23  11/8/25  $0.23    434,783    543,479   $0.23   5/8/26
Total  $1,100,200                  9,854,783    10,073,479         

 

(a)The replacement notes and new warrants are secured by mining claims and rights of the CuMo Project.

 

11

 

 

As of January 31, 2024, there were debt discounts and beneficial conversion features on the above notes payable of $476,201. The Company derecognized the unamortized beneficial conversion feature upon its adoption of ASU 2020-06 as described in Note 1.

 

On April 5, 2024, holders of $1,099,200 par value of Convertible Secured Notes issued between December 2022 and May 2023 elected to convert those notes to common stock under contract terms. As a result, we issued 9,854,783 shares of common stock to the respective holders.

 

NOTE 5 – BOND LIABILITIES

 

The Company has bond liabilities as of October 31, 2024, as follows:

 

   Principal Amount   Interest Rate   Note Date  Maturity Date  Collateral   Origination   Features 
Yin Yin Silver Limited  $500,000    8.50%  8/4/15  8/4/2025   (1)   (2)   (5)
Yin Yin Silver Limited  $500,000    8.50%  10/28/16  10/28/2026   (1)   (2)   (5)
Yin Yin Silver Limited  $250,000    8.50%  12/27/17  12/27/2024   (1)   (2)   (5)
Barry Swenson  $500,000    8.50%  12/31/17  12/31/2025   (1)   (2)   (5)
Don H. Adair or Joanne Adair  $125,000    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Joseph Swinford or Danielle Swinford  $50,000    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Brandon Swain or Sierra Swain  $50,000    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Scott Collins or Kendra Collins  $12,500    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Carl Collins or Ellen Collins  $12,500    8.50%  2/15/17  2/15/2024   (1)   (3)   (6)
Jim Hammerel  $5,000    8.50%  9/21/2017  9/21/2024   (1)   (2)   (5)
Bret Renaud  $5,000    8.50%  10/14/2017  10/14/2024   (1)   (2)   (5)
Elatam Group Ltd  $67,000    7.50%  8/24/2021  5/31/2028   (1)   (2)   (6)
James Hardy  $7,000    7.50%  8/24/2021  5/31/2028   (1)   (2)   (6)
Acepac Holdings  $1,000,000    7.50%  8/24/2021  5/31/2028   (1)   (4)   (6)
Rick Ward  $15,000    7.50%  8/24/2021  5/31/2028   (1)   (2)   (6)
Robert & Joan Sweetman  $10,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Michael Swenson  $10,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Connie Sun  $3,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Elizabeth Enoch  $10,000    8.00%  8/1/2018  7/1/2025   (1)   (2)   (6)
William C. Stanton and Carol Stanton  $3,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Total  $3,135,000                           

 

  (1) All notes above are secured by the following collateral: all the assets of Idaho CuMo except for the following patented lode mining claims located in Section 13, Township 8 North, Range 5 East, Boise Meridian, Boise County, Idaho, as depicted on Mineral Survey 1706: (i) Blackbird, (ii) Red Flag, (iii) Enterprise, (iv) Enterprise Fraction, (v) Commonwealth, (vi) Baby Mine. Each Note will rank pari passu with all other Notes.
  (2) Financial investment by accredited investor.
  (3) Issued in exchange for 20 unpatented mining claims located approximately 10 miles northeast of Pioneerville, Idaho.
  (4) Issued to settle litigation between MultiMetal Development Ltd. (former parent company of Idaho Copper Corp) and Acepac Holdings.
  (5) Interest capitalized; accrual dates 6/30 and 12/31.
  (6) Interest paid in cash on 6/30 and 12/31.
  (7) On September 25, 2023, these notes were extended from February 15, 2024, to February 15, 2025. The extension was analyzed for modification versus extinguishment and was determined to be a modification.

 

12

 

 

NOTE 6 – RELATED PARTY TRANSACTIONS

 

As of October 31, 2024, the Company has accrued compensation of $388,971 for its officers as recorded in accrued expenses to related parties. The Company compensated its officers $858,500 for the nine months ended October 31, 2024.

 

On January 23, 2023, the Company issued convertible notes payable to the following: Steven Rudofsky (“Rudofsky”), former Chairman and CEO, for $125,000; Feehan Partners LP (“Feehan”), controlled by Robert Scannell (“Scannell”), CFO and Director, for $87,334 and $112,666; Andrew Brodkey (“Brodkey”). CEO, COO and Director, for $98,000; and Shaun Dykes (“Dykes”), Vice President and Director, for $150,000 (issued to Dykes and related parties to Dykes). On April 5, 2024, Rudofsky, Feehan, Brodkey, and Dykes converted notes payable of $125,000, $200,000, $98,000, and $30,000, respectively, into 1,666,667, 2,666,666, 1,306,667, and 400,000 shares of common stock, respectively (see Note 4).

 

On April 3, 2024, the officers of the company, Rudofsky, Brodkey, and Scannell each elected to exercise 5,360,000 vested stock options with a strike price of $0.125 and an expiration date of September 30, 2027. All options were exercised on a cashless basis, resulting in the issuance of 3,385,000 shares per officer, or a total of 11,055,000 common shares.

 

On April 4, 2024, Feehan and Brodkey executed cashless conversion of 2,666,666 and 1,306,667 warrants, respectively, into 1,666,666 and 816,666 shares of common stock, respectively.

 

On April 6, 2024, Dykes executed cashless conversion of 400,000 warrants into 251,250 shares of common stock.

 

On April 8, 2024, Rudofsky executed cashless conversion of 1,666,667 warrants into 1,041,667 shares of common stock.

 

On May 1, 2024, Rudofsky, Brodkey, and Scannell each elected to convert accrued compensation of $31,250, $17,500, and $62,500, respectively, into 195,313, 109,375, and 390,625 shares of common stock, respectively.

 

On August 2, 2024, Brodkey, Rudofsky, and Scannell each elected to convert accrued compensation of $42,500, $31,250, and $87,500, respectively, into 170,000, 125,000, and 350,000 shares of common stock, respectively.

 

On September 25, 2024, the Company issued stock incentives to Brodkey (2,570,000 shares valued at $565,400), Scannell (2,500,000 shares valued at $550,000), and Rudofsky (125,000 shares valued at $27,500).

 

As of October 31, 2024, the Company has payables of $54,000 to Brodkey.

 

NOTE 7 – STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

The Company has authorized share capital of 10,000,000 shares of preferred stock with par value of $0.001.

 

On January 12, 2024, we entered into Unit Subscription Purchase Agreements (“Subscription Agreements”) with purchasers for an aggregate of 23 (“Units”) at a price of $12,000 per Unit. Each Unit comprised of one (1) share of Series A Convertible Non-Voting Preferred Stock, $0.001 par value per share (the “Series A Preferred Stock”), and (ii) 62,500 common stock purchase warrants (the “Warrants”). The rights and preferences of the Series A Preferred Stock, include without limitation, the right of each holder thereof to convert each share of Series A Preferred Stock into 50,000 shares of the Company’s common stock, par value $0.001 par value per share (“Common Stock”), as set forth in the Certificate of Designation of Series A Convertible Non-Voting Preferred Stock (the “Certificate of Designation”). The Warrant holders have the right to exercise the Warrants for three (3) years at an exercise price of $0.24 per share of Common Stock. The Units were offered and sold in reliance upon exemptions from the registration requirements provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) of Regulation D promulgated thereunder. The Company has agreed to file a registration statement to cover the re-sale of the shares of Common Stock issuable upon the conversion of the Series A Preferred Stock, and upon the exercise of the Warrants. The Company intends to utilize the net proceeds from the sale of the Units in the Offering for working capital and general corporate purposes.

 

The warrants issued through January 31, 2024, had a Black-Scholes fair value of $156,746 for the 1,125,000 warrants issued.

 

Stock price  $ 0.070.20 
Exercise price  $0.24 
Expected volatility   521 -1,042%
Expected term (years)   3 
Risk free rate   4.054.45%
Dividends   0%

 

Between February and October 2024, we entered into subscription agreements (each a “Subscription Agreement”) with certain accredited investors (each, a “Subscriber” and collectively, the “Subscribers”), pursuant to which the Company offered and sold to the Subscribers in a private placement offering (the “Offering”), units (each, a “Unit” and, collectively, the “Units”), for a purchase price of $12,000 per Unit, for gross proceeds of $1,964,000. Each Unit consists of one (1) share of the Company’s Series A Convertible Non-Voting Preferred Stock, par value $0.001 per share (the “Preferred Stock”), and (ii) 62,500 common stock purchase warrants (the “Warrants”). Each share of Preferred Stock converts into 50,000 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”). The Warrant entitles the holders to shares of Common Stock for three (3) years, at an exercise price of $0.24 per share.

 

13

 

 

As of October 31, 2024, and January 31, 2024, the Company had 186.67 and 23 shares of Series A Preferred Stock issued and outstanding, respectively.

 

Common Stock

 

The Company has authorized share capital consisted of 500,000,000 shares of common stock with par value of $0.001.

 

As described in Note 4, the Company issued certain shares of its common stock for the conversion of convertible notes payable during the period ended October 31, 2024.

 

As described in Note 6, the Company issued certain shares of its common stock to related parties during the period ended October 31, 2024.

 

On May 1, 2024, Rudofsky, Brodkey, and Scannell each elected to convert accrued compensation of $31,250, $17,500, and $62,500, respectively, into 195,313, 109,375, and 390,625 shares of common stock, respectively.

 

During May 2024, the Company issued 1,041,667 shares of common stock to an officer as a result of the cashless exercise of their warrants.

 

On August 2, 2024, Brodkey, Rudofsky, and Scannell each elected to convert accrued compensation of $42,500, $31,250, and $87,500, respectively, into 170,000, 125,000, and 350,000 shares of common stock, respectively. Other employees and non-employees converted compensation of $574,750 into 439,000 shares of common stock.

 

On September 25, 2024, the Company issued stock incentives to Brodkey (2,570,000 shares valued at $565,400), Scannell (2,500,000 shares valued at $550,000), and Rudofsky (125,000 shares valued at $27,500). The Company also issued stock incentives to employees and non-employees (375,000 shares valued at $82,500).

 

For the nine months ended October 31, 2024, the Company issued 1,039,096 shares of common stock for non-officer services.

 

As of October 31, 2024, the Company had 256,942,937 shares issued, issuable, and outstanding.

 

Options

 

On January 23, 2023, as part of the RTO, the Company accepted the assignment of the stock options for common stock from ICUMO to the Company, as consented by the parties. The Company has 56,615,000 options issued to various officers, directors, and employees, based on milestones. As of January 31, 2024, and October 31, 2024, 22,646,000 and 6,566,000 options are vested. The exercise price for the options is $0.125 and they expire on December 31, 2027. The Company recognized $189,248 the period ended October 31, 2024, in stock-based compensation expense related to the estimated vesting of these options. As of October 31, 2024, none of the remaining milestones necessary for these options to vest have been met. The remaining additional compensation to be recognized as these options vest is approximately $568,000 during fiscal 2025 based on the current estimated time to reach the milestones.

 

The remaining vesting milestones required to be met are (1) obtaining an updated PEA, (2) an uplist of the Company’s common stock to a national exchange and (3) the successful raising of $5 million or more in new capital. Each of these milestones vest an additional 20% of the options upon being met and were estimated to have a 50% probability of being met as of January 31, 2024. Management reviews the estimate of meeting each probability as well as the related timing at each reporting period.

 

On April 3, 2024, Brodkey, Scannell, Rudofsky, and Dykes executed cashless conversions of 5,360,000 vested options each into 3,685,000 shares of common stock each.

 

Warrants

 

On April 4, 2024, Feehan and Brodkey executed cashless conversion of 2,666,666 and 1,306,667 warrants, respectively, into 1,666,666 and 816,666 shares of common stock, respectively.

 

On April 6, 2024, Dykes executed cashless conversion of 400,000 warrants into 251,250 shares of common stock.

 

On April 6, 2024, four warrant holders executed cashless conversion of 1,200,000 warrants into 753,750 shares of common stock.

 

On April 8, 2024, Rudofsky executed cashless conversion of 1,666,667 warrants into 1,041,667 shares of common stock.

 

As of October 31, 2024, the Company had 2,614,783 warrants outstanding with an exercise price of $0.15, which relate to the convertible notes dated January 23, 2023 (see Note 4), and 1,093,479 warrants outstanding with an exercise price of $0.23, which relate to the convertible notes dated May 8, 2023 (see Note 4).

 

Stock-based Compensation Expense

 

The Company recognizes stock-based compensation using the straight-line method over the requisite service period or derived service period. The Company recognized stock-based compensation for the three months ended October 31, 2024, and 2023 of $1,704,024 and $0, respectively, and for the nine months ended October 31, 2024, and 2023 of $2,258,080 and $140,739, respectively.

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

The Company is subject, from time to time, to claims by third parties under various legal disputes. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on the Company’s liquidity, financial condition and cash flows.

 

Certain conditions may exist as of the date the condensed consolidated financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

14

 

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the nature of the guarantee would be disclosed.

 

The Company entered into a new long-term lease agreement for warehouse space in Idaho. The lease began on April 1, 2024, with an initial period of 3 years and an optional 3-year renewal at the end of the initial term. The Company may cancel the lease at any time after 13 months from the effective date of the lease by providing a 3-month notice of cancellation. The base lease payment is $3,600 through January 1, 2026, at which point base rent increases to $3,700 until January 1, 2027, at which point it increases to $3,800 until January 1, 2028, at which point it increases to $3,900. Prior to entering into this lease agreement, the Company was a party to a month-to-month lease which it had not terminated. The lessor and the Company agreed regain access to the warehouse including obtaining access to the Company’s property contained within such warehouse, the lessor agreed to the following additional payments. A single payment of $100,000 which was paid on March 5, 2024, and $6,000 per month beginning May 1, 2024, and ending on February 1, 2025.

 

Initially, the Company measure the right of use asset and liability associated with its office lease using the following inputs:

 

Remaining lease term (in years)   1.08 
Discount rate   12%

 

The remaining term of the lease was based on the amount of time left before the Company may exercise its right to cancel the lease which is 13 months.

 

The Company considered whether it was probable it would exercise and extend beyond the initial 3-year term and determine it was not probable that the Company would exercise this renewal option.

 

The Company records rent on straight-line basis over the terms of the underlying lease. Estimated future minimum lease payments under the lease are as follows:

 

Year Ending January 31,  Amount 
2025  $43,200 
Total remaining lease payments   43,200 
Less: imputed interest   22,357 
Present value of remaining lease payments  $20,843 

 

The rent expense for the nine months October 31, 2024, and 2023 was $143,085 and $21,000 respectively.

 

NOTE 9 – INCOME TAXES

 

As of October 31, 2024, and January 31, 2024, the Company has net operating loss carry forwards of $1,312,283 and $751,916, respectively, which may be available to reduce future years’ taxable income through 2043. The Company’s net operating loss carry forwards may be subject to annual limitations, which could reduce or defer the utilization of the losses as a result of an ownership change as defined in Section 382 of the Internal Revenue Code.

 

The Company’s tax expense differs from the “expected” tax expense for Federal income tax purposes (computed by applying the United States Federal tax rate of 21% and state rate of 5% to loss before taxes for fiscal years 2025 and 2024), as follows:

 

   October 31,   January 31, 
   2024   2024 
Tax expense (benefit) at the statutory rate  $(452,604)  $(285,980)
State income taxes, net of federal income tax benefit   (107,763)   (68,090)
Change in valuation allowance   560,367    354,070 
Total  $-   $- 

 

The tax effects of the temporary differences between reportable financial statement income and taxable income are recognized as deferred tax assets and liabilities.

 

The tax year 2023 remains open for examination by federal agencies and other jurisdictions in which it operates.

 

The tax effect of significant components of the Company’s deferred tax assets and liabilities at October 31, 2024 and January 31, 2024 are as follows:

 

   October 31, 2024   January 31, 2024 
Deferred tax assets:          
Net operating loss carryforward  $1,312,283   $751,916 
Timing differences   -    - 
Total gross deferred tax assets   1,312,283    751,916 
Less: Deferred tax asset valuation allowance   (1,312,283)   (751,916)
Total net deferred taxes  $-   $- 

 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.

 

15

 

 

Because of the historical earnings history of the Company, the net deferred tax assets for 2023 were fully offset by a 100% valuation allowance. The valuation allowance for the remaining net deferred tax assets was $1,312,283 and $751,916 as of October 31, 2024, and January 31,2024, respectively.

 

NOTE 10 – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events from the condensed consolidated balance sheet through the date of this filing and determined there were no events to disclose or that require recognition in the accompanying condensed consolidated financial statements.

 

On November 4, 2024, the Company issued a secured promissory note for $25,000 to Feehan. The note accrues interest at 10% and is due on November 4, 2025.

 

On November 5, 2024, Brodkey and Scannell each elected to convert accrued compensation of $42,500 and $87,500, respectively, into 193,182 and 397,727 shares of common stock, respectively. Other employees and non-employees converted compensation of $67,500 into 306,818 shares of common stock.

 

On November 5, 2024, Rudofsky exercised 500,000 warrants with a $0.15 exercise price into 500,000 shares of common stock for $75,000.

 

Offering

 

The Company filed a registration statement on Form S-1 with the Securities and Exchange Commission (“SEC”) on July 11, 2024, to offer and resell up to 94,126,642 shares of common stock by selling stockholders consisting of (i) up to 9,283,333 shares of common stock issuable upon the conversion of 185.66 shares of Series A Convertible Non-Voting Preferred Stock, $0.001 par value per share sold in a private placement offering with Newbridge Securities Corporation acting as the sole placement agent (the “Newbridge Private Placement Offering”) (ii) up to 11,604,167 shares of common stock issuable upon the exercise of warrants sold in the Newbridge Private Placement Offering, (iii) 813,333 shares of common stock issued to the placement agent of the Newbridge Private Placement Offering, (iv) 66,794,143 shares of common stock issued pursuant to the January 23, 2023 share exchange with the former shareholders of ICUMO, (v) 4,333,333 shares of common stock sold a private placement offering on December 15, 2022, (vi) 880,000 shares of common stock issuable upon conversion of the principal and accrued interest of two convertible promissory notes in the aggregate principal amount of $201,200 in total, at a price of $0.23 per share, issued to certain selling stockholders on April 5, 2024, and (vii) 418,333 shares of common stock issued in consideration of consulting fees to various consultants.

 

The registration statement has not yet been declared effective by the SEC.

 

16

 

 

ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The statements contained in the following MD&A and elsewhere throughout this Quarterly Report on Form 10-Q, including any documents incorporated by reference, that are not historical facts, including statements about our beliefs and expectations, are “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements preceded by, followed by or that include the words “may,” “could,” “would,” “should,” “believe,” “expect,” “anticipate,” “plan,” “estimate,” “target,” “project,” “intend” and similar words or expressions. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements.

 

These forward-looking statements, which reflect our management’s beliefs, objectives, and expectations as of the date hereof, are based on the best judgment of our management. All forward-looking statements made by us in this Form 10-Q are based only on information currently available to us and speak only as of the date on which they are made. Such forward-looking statements are subject to certain risks, uncertainties and assumptions relating to factors that could cause actual results to differ materially from those anticipated in such statements, including, without limitation, the following: economic, social and political conditions, global economic downturns resulting from extraordinary events such as the COVID-19 pandemic and other securities industry risks; interest rate risks; liquidity risks; credit risk with clients and counterparties; risk of liability for errors in clearing functions; systemic risk; systems failures, delays and capacity constraints; network security risks; competition; reliance on external service providers; new laws and regulations affecting our business; net capital requirements; extensive regulation, regulatory uncertainties and legal matters; failure to maintain relationships with employees, customers, business partners or governmental entities; the inability to achieve synergies or to implement integration plans and other consequences associated with risks and uncertainties detailed in our filings with the SEC, including our most recent filings on Forms 8-K, 10-K and 10-Q.

 

We caution that the foregoing list of factors is not exclusive, and new factors may emerge, or changes to the foregoing factors may occur, that could impact our business. We undertake no obligation to publicly update or revise these statements, whether as a result of new information, future events or otherwise, except to the extent required by the federal securities laws.

 

This discussion should be read in conjunction with our financial statements filed on our Form 8-K on January 27, 2023, our 2024 Form 10-K, and our condensed consolidated financial statements and the notes thereto contained elsewhere in this Quarterly Report on Form 10-Q.

 

Nature of Operations

 

The Company is in the process of exploring its mineral right interests in the United States and at the date of these condensed consolidated financial statements, has not yet determined whether any of its mineral properties contain economically recoverable mineral reserves. Accordingly, the carrying amount of mineral right interests represents cumulative expenditures incurred to date and does not necessarily reflect present or future values. The recovery of these costs is dependent upon the discovery of economically recoverable mineral reserves and the ability of the Company to obtain the necessary financing to complete their exploration and development and to resolve any environmental, regulatory, or other constraints. Uncertainty also exists with respect to the recoverability of the carrying value of certain mineral right interests. The ability of the Company to realize its investment in resource properties is contingent upon the maintenance and integrity of the Company’s title to such properties.

 

Mining Property

 

To determine material mining operations in accordance with subpart 1300 of SEC Regulation S-K, management considered both quantitative and qualitative factors, assessed in the context of the Company’s overall business and financial condition. The Company concluded that, as of the date of the filing of this Report, its sole material mining operation is the CuMo Project. The Company will update its assessment of individual material mines on an annual basis.

 

The information relating to such sole material mining operation is contained in the technical report summary (“TRS”) relating to the CuMo Project prepared in compliance with the Item 601(b)(96) and subpart 1300 of Regulation S-K. Reference should be made to the full text of the TRS, a copy of which was filed as Exhibit 96.1 to the Current Report on Form 8-K, dated January 27, 2023.

 

Pursuant to Item 1302(b)(5) of Regulation S-K (17 C.F.R. §229.1302(b)(5)), the Company states that the TRS was prepared by Shaun M. Dykes, M. Sc. (Eng), P.Geo of Geologic Systems, Ltd. Mr. Dykes is also serving as a technical advisor to the registrant. Mr. Dykes meets the qualifications specified under the definition of “qualified person” under Item 1300 of Regulation S-K.

 

The CuMo Project currently consists of one hundred and twenty-six (126) federal unpatented lode mining claims, and six (6) patented mining claims. In total, the project comprises approximately 2,640 acres. The unpatented lode mining claims and patented claims are situated in an unorganized mining district, in Boise County, Idaho, spanning Sections in Township 7N and 8N, Range 5E and 6E, Boise Meridian.

 

No assurances can be given that any of these plans will come to fruition or that if implemented they will necessarily yield positive results.

 

Independent Valuation

 

On March 3, 2023, an independent valuation firm issued a valuation of the assets, specifically the CuMo project in Boise County, Idaho, acquired by the Company in the ICUMO transaction. The CuMo project is a molybdenum-copper deposit that will be developed as an open pit mining operation. The fair market value of the assets were $23,919,754.

 

17

 

 

Off-balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

 

Results of Operations

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and notes thereto for the nine months ended October 31, 2024, and 2023, and related management discussion herein.

 

Our condensed consolidated financial statements are stated in U.S. Dollars and are prepared in accordance with US GAAP.

 

Going Concern Qualification

 

Several conditions and events cast substantial doubt about the Company’s ability to continue as a going concern. The Company has incurred cumulative net losses of $36,438,438 from its inception to October 31, 2024, and requires capital for its contemplated operational and marketing activities to take place. The Company’s ability to raise additional capital through debt or future issuances of capital stock is unknown. The obtainment of additional financing, the successful development of the Company’s contemplated plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raises substantial doubt about the Company’s ability to continue as a going concern.

 

For the three months ended October 31, 2024, compared to the three months ended October 31, 2023

 

Revenue

 

The Company has had no revenue historically to date.

 

Operating Expenses

 

The Company had operating expenses of $2,204,968 for the three months ended October 31, 2024, compared to $436,726 for the three months ended October 31, 2023. The increase was primarily due to the increase in stock-based compensation ($1,704,024 for the three months ended October 31, 2024 compared to $0 for the same period in 2023), professional fees ($285,336 for the three months ended October 31, 2024 compared to $100,821 for the same period in 2023), rent expense ($28,800 for the three months ended October 31, 2024 compared to $10,500 for the same period in 2023), and other general and administrative expenses ($126,808 for the three months ended October 31, 2024 compared to $42,905 for the same period in 2023), offset by the decrease in payroll and related expenses ($60,000 for the three months ended October 31, 2024 compared to $282,500 for the same period in 2023. The increase in stock-based compensation was primarily due to the conversion of officers’ accrued compensation into common stock. The increase in rent expense was due to larger facility needs. The increase in other general and administrative costs was primarily due to scanning services for the quarter. The decrease in payroll and related expenses was primarily due to officers converting accrued compensation into common stock.

 

Other Income / Expenses

 

The Company had other expenses, net, of $147,613 for the three months ended October 31, 2024, compared to $143,732 of expense for the three months ended October 31. 2023.

 

Net Loss

 

The Company had a net loss of $2,352,581 for the three months ended October 31, 2024, compared to $580,459 for the three months ended October 31, 2023.

 

For the nine months ended October 31, 2024, compared to the nine months ended October 31, 2023

 

Revenue

 

The Company has had no revenue historically to date.

 

Operating Expenses

 

The Company had operating expenses of $4,123,390 for the nine months ended October 31, 2024, compared to $1,236,821 for the nine months ended October 31, 2023. The increase was primarily due to the increase in stock-based compensation expenses ($2,258,080 for the nine months ended October 31, 2024 compared to $140,739 for the same period in 2024), professional fees ($625,945 for the nine months ended October 31, 2024 compared to $357,622 for the same period in 2023), rent expense ($171,885 for the nine months ended October 31, 2024 compared to $31,500 for the same period in 2023), and other general and administrative expenses ($554,830 for the nine months ended October 31, 2024 compared to $67,459 for the same period in 2023), offset by the decrease in payroll and payroll related expenses ($512,650 for the nine months ended October 31, 2024 compared to $639,500 for the same period in 2023). The decrease in payroll and related expenses is related to the conversion of accrued payroll into common stock offset by a pay increase for two officers. The increase in rent expense is primarily due to a settlement of $100,000 and the larger facility rented. The increase in other general and administrative expenses was primarily due to scanning services of $413,608. The increase in stock-based compensation was primarily due to conversions of accrued compensation for officers and the issuances of common stock to various third parties for services. The increase in professional fees relates to increased services required for funding activities and the preparation for the filing of Form S-1.

 

Other Income / Expenses

 

The Company had other expenses, net, of $309,439 for the nine months ended October 31, 2024, compared to expenses of $506,170 for the nine months ended October 31. 2023.

 

18

 

 

Net Loss

 

The Company had a net loss of $4,432,829 for the nine months ended October 31, 2024, compared to $1,742,989 for the nine months ended October 31, 2023.

 

Liquidity and Capital Resources

 

As of October 31, 2024, the Company had cash of $18,731. We do not have sufficient resources to effectuate our business. We expect to incur expenses offset by revenues during the next twelve months of operations. We estimate that these expenses will be comprised primarily of general expenses including overhead, legal and accounting fees. The Company does not project revenue for the next few years, as is typical in mining companies. The Company has and will continue to raise capital to fund the expenses. To maintain our plan of growth, we need to raise a minimum of an additional $750,000. These factors raise substantial doubts about the Company’s ability to continue as a going concern.

 

Operations used cash of $2,071,799 for the nine months ended October 31, 2024, compared to cash used of $614,860 for the same period in 2023.

 

We used cash in financing activities of $0 for the nine months ended October 31, 2024, compared to $0 for the same period in 2023.

 

We had cash provided by financing activities for the nine months ended October 31, 2024, of $2,060,384 compared to $201,200 for the same period in 2023.

 

We will have to raise funds to pay for our expenses. We may have to borrow money from shareholders or issue debt or equity or enter into a strategic arrangement with a third party. There can be no assurance that additional capital will be available to us. We currently have no arrangements or understandings with any person to obtain funds through bank loans, lines of credit or any other sources. Since we have no such arrangements or plans currently in effect, our inability to raise funds for our operations will have a severe negative impact on our ability to remain a viable company.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

The Securities and Exchange Commission defines the term “disclosure controls and procedures” to mean a company’s controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer’s management, including its chief executive and chief financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a system of controls and procedures in an effort to ensure that all information that it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC’s rules and forms and that information required to be disclosed is accumulated and communicated to the chief executive and interim chief financial officer to allow timely decisions regarding disclosure.

 

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer / Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, the Chief Executive Officer / Chief Financial Officer have concluded that the Company’s disclosure controls and procedures are not effective as of such date. The Chief Executive Officer / Chief Financial Officer have determined that the Company continues to have the following deficiencies which represent a material weakness:

 

  The Company does not have a majority of independent directors;
  Lack of in-house personnel with the technical knowledge to identify and address some of the reporting issues surrounding certain complex or non-routine transactions. With material, complex and non-routine transactions, management has and will continue to seek guidance from third-party experts and/or consultants to gain a thorough understanding of these transactions;
  Insufficient personnel resources within the accounting function to segregate the duties over financial transaction processing and reporting;
  Insufficient written policies and procedures over accounting transaction processing and period end financial disclosure and reporting processes; and
  To remediate our internal control weaknesses, management intends to implement the following measures: as funding permits, the Company will add sufficient accounting personnel to properly segregate duties and to effect a timely, accurate preparation of the financial statements; the Company will hire staff technically proficient at applying U.S. GAAP to financial transactions and reporting; and upon the hiring of additional accounting personnel, the Company will develop and maintain adequate written accounting policies and procedures.

 

The additional hiring is contingent upon The Company’s efforts to obtain additional funding through equity or debt and the results of its operations. Management hopes to secure funds in the coming fiscal year but provides no assurances that it will be able to do so.

 

Limitations on the Effectiveness of Controls

 

The Company’s officers do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all error and fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of the control system must reflect that there are resource constraints and that the benefits must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

 

19

 

 

Changes in Internal Control Over Financial Reporting

 

During the fiscal quarter covered by this Quarterly Report, there has been a significant change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. With the transaction with ICUMO, the Company has an independent accounting company which has provided a separation of duties.

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these, or other matters may arise from time to time that may harm our business. Except as set forth below, we are currently not aware of any such pending or threatened legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition, or operating results.

 

Item 1A. Risk Factors

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

The enacted Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) requires the operators of mines to include in each periodic report filed with the SEC certain specified disclosures regarding the Company’s history of mine safety. The Company did not operate any mines during the period covered by this Report and currently does not operate any mines and, as such, is not subject to disclosure requirements regarding mine safety that were imposed by the Dodd-Frank Act.

 

Item 5. Other Information

 

None.

 

20

 

 

Item 6. Exhibits

 

Exhibit Number   Description
2.1   Share Exchange Agreement, by and between Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.), International CuMo Mining Corporation, and the shareholders of International CuMo Mining Corporation, dated January 23, 2023 (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
3.1   Amended and Restated Articles of Incorporation (Incorporated by reference to the exhibits to our Form 8-K filed with the SEC on October 14, 2022)
3.2   Amended and Restated Bylaws (Incorporated by reference to the exhibits to our Form 8-K filed with the SEC on October 14, 2022)
3.3   Certificate of Amendment to Articles of Incorporation, filed March 9, 2023 (Incorporated by reference to the exhibits to our Form 8-K filed with the SEC on March 10, 2023)
3.4   Certificate of Designation of the Series A Convertible Non-Voting Preferred Stock (Incorporated by reference to the exhibits to our Form 8-K filed with the SEC on January 17, 2024)
4.2   Form 2021 Warrant (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
4.3   Corrected Form of Replacement Warrant (Incorporated by reference to the exhibits to our Current Report on Form 8-K/A filed with the SEC on February 14, 2023).
4.4   Form Lock-Up Agreement (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
4.5   Form of 8.5% Secured Non-Convertible Note (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
4.6   7.5% Secured Note Indenture, dated August 24, 2021, by and between International CuMo Mining Corporation and Computershare Trust Company of Canada (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
10.1   Form Incentive Stock Option Agreement (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
10.2   Merger Agreement, dated as of November 20, 2020, by and among Crystal Globe Limited, Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.), Dynamic Elite International Limited and Joway Merger Subsidiary Limited, (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on November 25, 2020)
10.3   Stock Purchase Agreement, dated as of January 31, 2022, by and among Crystal Globe Limited, Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.) and JHP Holdings, Inc. (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on February 10, 2022)
10.4   Debt Assignment and Release Agreement, dated January 23, 2023, by and among Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.) and JHP Holdings, Inc. (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
10.5   Option Agreement, dated October 13, 2004, by and between Cumo Molybdenum Mining Inc. and Mosquito Consolidated Gold Mines Limited, as amended January 14, 2005 (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
10.6   Mining Claims Agreement, dated July 25, 2017, by and among American CuMo Mining Corporation, International CuMo Mining Corporation, CuMo Molybdenum Mining Inc., Western Geoscience Inc., and Thomas Evans (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
10.7   Special Warranty Deed, between American CuMo Mining Corporation and International CuMo Mining Corporation (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
10.8   Loan Agreement, dated October 31, 2014, as amended March 26, 2015, and January 29, 2016, by and between International CuMo Mining Corporation and La Familia II LLC (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
10.9   MineSense Amenability Test Proposal, dated August 29, 2022, by and between MineSense Technologies Ltd. and International CuMo Mining Corporation (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
10.10   Management Agreement between International Cumo Mining Corporation and Robert W. Scannell dated December 15, 2022 (Incorporated by reference to the exhibits to our Form 10-K filed with the SEC on May 15, 2024).
10.11   Management Agreement between International Cumo Mining Corporation and Steven Rudofsky dated January 1, 2022 (Incorporated by reference to the exhibits to our Form 10-K filed with the SEC on May 15, 2024).
10.12   Management Agreement between International Cumo Mining Corporation and Andrew A. Brodkey dated December 15, 2021 (Incorporated by reference to the exhibits to our Form 10-K filed with the SEC on May 15, 2024).
10.13   Technical Advisory Agreement between International Cumo Mining Corporation and Mult-Metal Development Ltd. dated March 31, 2023 (Incorporated by reference to the exhibits to our Form 10-K filed with the SEC on May 15, 2024).
10.14   Form of Unit Subscription Purchase Agreement (Incorporated by reference to the exhibit to our Form 8-K filed with the SEC on January 17, 2024).
10.15   Form of Unit Subscription Purchase Agreement (Incorporated by reference to the exhibits to our Form 10-Q filed with the SEC on June 3, 2024).
23.1   Consent of Geologic Systems Ltd. regarding the CuMo Project (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
31.1*   Certification of the Principal Executive Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2*   Certification of Principal Accounting and Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1*   Certification of the Principal Executive Officer of Registrant pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2*   Certification of Principal Accounting and Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
96.1   Technical Report Summary and Resource Estimate, the CuMo Project, Boise National Forest, Boise County, Idaho, United States (Incorporated by reference to the exhibits to our Current Report on Form 8-K filed with the SEC on January 27, 2023).
101.INS*   Inline XBRL Instance Document.
101.SCH*   Inline XBRL Taxonomy Extension Schema Document.
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith

 

21

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

SIGNATURE   TITLE   DATE
         
/s/Andrew Brodkey   President and Chief Executive Officer (Principal Executive Officer)   December 12, 2024
Andrew Brodkey        
         
/s/ Robert Scannell   Chief Financial Officer (Principal Financial and Accounting Officer)   December 12, 2024
Robert Scannell        

 

22

 

 

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Andrew Brodkey, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Idaho Copper Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 12, 2024  
   
/s/ Andrew Brodkey  
Andrew Brodkey  
Chief Executive Officer  
(Principal Executive Officer)  

 

 

 

 

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Robert Scannell, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Idaho Copper Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 12, 2024  
   
/s/ Robert Scannell  
Robert Scannell  
Chief Financial Officer  
(Principal Financial and Accounting Officer)  

 

 

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES OXLEY ACT OF 2002

CERTIFICATION

 

In connection with the Quarterly Report of Idaho Copper Corporation (the “Company”) on Form 10-Q for the period ended October 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Andrew Brodkey, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Andrew Brodkey  
Andrew Brodkey  
Chief Executive Officer  
(Principal Executive Officer)  
   
December 12, 2024  

 

 

 

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES OXLEY ACT OF 2002

CERTIFICATION

 

In connection with the Quarterly Report of Idaho Copper Corporation (the “Company”) on Form 10-Q for the period ended October 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert Scannell, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Robert Scannell  
Robert Scannell  
Chief Financial Officer  
(Principal Financial and Accounting Officer)  
   
December 12, 2024  

 

 

 

v3.24.3
Cover - shares
9 Months Ended
Oct. 31, 2024
Dec. 11, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Oct. 31, 2024  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2025  
Current Fiscal Year End Date --01-31  
Entity File Number 333-108715  
Entity Registrant Name IDAHO COPPER CORPORATION  
Entity Central Index Key 0001263364  
Entity Tax Identification Number 98-0221494  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 800 W. Main Street  
Entity Address, Address Line Two Suite 1460  
Entity Address, City or Town Boise  
Entity Address, State or Province ID  
Entity Address, Postal Zip Code 83702  
City Area Code (208)  
Local Phone Number 274-9220  
Title of 12(b) Security Common  
Trading Symbol COPR  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   256,942,937
v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Oct. 31, 2024
Jan. 31, 2024
Current assets    
Cash $ 18,731 $ 30,146
Prepaid expenses 134,716 21,624
Total current assets 153,447 51,770
Right of use asset 20,843
Deposit 100,000 100,000
Total assets 274,290 151,770
Current liabilities    
Accounts payable and accrued expenses 385,958 434,519
Accrued interest, current portion 284,279 1,115,723
Note payable 25,000
Lease liability 20,843
Bond liabilities, current portion 546,000
Total current liabilities 1,651,051 1,920,377
Non-current liabilities    
Bond liabilities, non-current portion 2,589,000 3,135,000
Convertible notes payable, net of discounts 623,999
Accrued interest, non-current portion 1,590,724 533,003
Total non-current liabilities 4,179,724 4,292,002
Total liabilities 5,830,775 6,212,379
Commitments and contingencies (Note 8)
Stockholders’ deficit    
Preferred stock, $0.001 par value, 10,000,000 shares authorized, 186.67 and 23 shares issued and outstanding at October 31, 2024 and January 31, 2024, respectively
Common stock, $0.001 par value, 500,000,000 shares authorized, 256,942,937 and 214,647,732 shares issued and outstanding at October 31, 2024 and January 31, 2024, respectively 256,943 214,648
Additional paid-in capital 30,625,010 25,336,048
Subscription receivable (11,000)
Accumulated deficit (36,438,438) (31,600,305)
Total stockholders’ deficit (5,556,485) (6,060,609)
Total liabilities and stockholders’ deficit 274,290 151,770
Related Party [Member]    
Current liabilities    
Accrued expenses to related parties $ 388,971 $ 370,135
v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Oct. 31, 2024
Jan. 31, 2024
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 186.67 23
Preferred stock, shares outstanding 186.67 23
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 500,000,000 500,000,000
Common stock, shares issued 256,942,937 214,647,732
Common stock, shares outstanding 256,942,937 214,647,732
v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Income Statement [Abstract]        
Revenue
Operating expenses        
Professional fees 285,336 100,821 625,945 357,622
Payroll and related expenses 60,000 282,500 512,650 639,500
Rent expense 28,800 10,500 171,885 31,500
Stock-based compensation 1,704,024 2,258,080 140,739
Other general and administrative expenses 126,808 42,905 554,830 67,459
Total operating expenses 2,204,968 436,726 4,123,390 1,236,820
Operating loss (2,204,968) (436,726) (4,123,390) (1,236,820)
Other income (expense)        
Amortization of beneficial conversion feature (68,566) (203,812)
Amortization of debt discount (11,316) (19,490) (22,633)
Interest income 440 6,846
Interest expense (148,053) (63,851) (296,795) (279,725)
Total other income (expense) (147,613) (143,733) (309,439) (506,170)
Net loss $ (2,352,581) $ (580,459) $ (4,432,829) $ (1,742,990)
v3.24.3
Condensed Consolidated Statement of Operations (Unaudited) - $ / shares
3 Months Ended 9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Income Statement [Abstract]        
Basic net loss per common share $ (0.01) $ (0.00) $ (0.02) $ (0.01)
Diluted net loss per common share $ (0.01) $ (0.00) $ (0.02) $ (0.01)
Basic weighted average common shares outstanding 253,460,307 210,365,353 242,282,623 210,175,251
Diluted weighted average common shares outstanding 253,460,307 210,365,353 242,282,623 210,175,251
v3.24.3
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
Total
Balance at Jan. 31, 2023 $ 208,458 $ 23,059,223 $ (27,888,258) $ (4,620,577)
Balance, shares at Jan. 31, 2023 208,457,823        
Common stock options issued for services $ 879 139,860 140,739
Common stock options issued for services, shares   879,628        
Net loss (575,001) (575,001)
Balance at Apr. 30, 2023 $ 209,337 23,199,083 (28,463,259) (5,054,839)
Balance, shares at Apr. 30, 2023 209,337,451        
Balance at Jan. 31, 2023 $ 208,458 23,059,223 (27,888,258) (4,620,577)
Balance, shares at Jan. 31, 2023 208,457,823        
Net loss           (1,742,990)
Balance at Oct. 31, 2023 $ 213,182 23,568,169 (29,631,249) (5,849,898)
Balance, shares at Oct. 31, 2023 213,181,524        
Balance at Apr. 30, 2023 $ 209,337 23,199,083 (28,463,259) (5,054,839)
Balance, shares at Apr. 30, 2023 209,337,451        
Net loss (587,531) (587,531)
Warrants issued 103,846 103,846
Balance at Jul. 31, 2023 $ 209,337 23,302,929 (29,050,790) (5,538,524)
Balance, shares at Jul. 31, 2023 209,337,451        
Net loss (580,459) (580,459)
Conversion of convertible notes payable $ 3,845 265,240 269,085
Conversion of convertible notes payable, shares   3,844,073        
Balance at Oct. 31, 2023 $ 213,182 23,568,169 (29,631,249) (5,849,898)
Balance, shares at Oct. 31, 2023 213,181,524        
Balance at Jan. 31, 2024 $ 214,648 25,336,048 (11,000) (31,600,305) (6,060,609)
Balance (Accounting Standards Update 2020-06 [Member]) at Jan. 31, 2024 (405,305) (405,305)
Balance, shares at Jan. 31, 2024 23 214,647,732        
Net loss (1,044,266) (1,044,266)
Conversion of convertible notes payable $ 12,848 1,035,945 1,048,793
Conversion of convertible notes payable, shares   12,848,116        
Sale of preferred stock 1,742,300 11,000 1,753,300
Sale of preferred stock, shares 139          
Exercise of warrants $ 4,781 (4,781)
Exercise of options, shares   4,781,249        
Exercise of options $ 14,740 (14,740)
Exercise of options, shares   14,740,000        
Stock-based compensation 189,248 189,248
Balance at Apr. 30, 2024 $ 247,017 28,284,020 (33,049,876) (4,518,839)
Balance, shares at Apr. 30, 2024 162 247,017,097        
Balance at Jan. 31, 2024 $ 214,648 25,336,048 (11,000) (31,600,305) (6,060,609)
Balance (Accounting Standards Update 2020-06 [Member]) at Jan. 31, 2024 (405,305) (405,305)
Balance, shares at Jan. 31, 2024 23 214,647,732        
Net loss           (4,432,829)
Balance at Oct. 31, 2024 $ 256,943 30,625,010 (36,438,438) (5,556,485)
Balance, shares at Oct. 31, 2024 186.67 256,942,937        
Balance at Apr. 30, 2024 $ 247,017 28,284,020 (33,049,876) (4,518,839)
Balance, shares at Apr. 30, 2024 162 247,017,097        
Net loss (1,035,981) (1,035,981)
Sale of preferred stock 320,084 320,084
Sale of preferred stock, shares 23.67          
Stock-based compensation 1,888 362,920 364,808
Exercise of options
Stock based compensation, shares   1,888,173        
Exercise of warrant $ 1,042 (1,042)
Exercise of warrant, shares   1,041,667        
Costs related to sale of preferred stock (50,000) (50,000)
Balance at Jul. 31, 2024 $ 249,947 28,915,982 (34,085,857) (4,919,928)
Balance, shares at Jul. 31, 2024 185.67 249,946,937        
Net loss (2,352,581) (2,352,581)
Sale of preferred stock 12,000 12,000
Sale of preferred stock, shares 1          
Stock-based compensation $ 6,996 1,697,028 1,704,024
Stock based compensation, shares   6,996,000        
Balance at Oct. 31, 2024 $ 256,943 $ 30,625,010 $ (36,438,438) $ (5,556,485)
Balance, shares at Oct. 31, 2024 186.67 256,942,937        
v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Cash flows from operating activities:    
Net loss $ (4,432,829) $ (1,742,990)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 2,258,080 140,739
Amortization of beneficial conversion feature 203,812
Amortization of debt discount 19,490 22,633
Change in assets and liabilities:    
Prepaid expenses (113,092) (24,472)
Accounts payable and accrued expenses (52,400) 123,032
Accrued expenses - related party 22,676 481,387
Accrued interest 226,276 180,999
Net cash used in operating activities (2,071,799) (614,860)
Cash flows from financing activities:    
Proceeds from convertible notes payable 201,200
Proceeds from note payable 25,000
Proceeds from sale of preferred stock 2,035,384
Net cash provided by financing activities 2,060,384 201,200
Net decrease in cash (11,415) (413,660)
Cash at beginning of period 30,146 431,374
Cash at end of period 18,731 17,714
Cash paid for interest
Cash paid for taxes
Non-cash investing and financing activities:    
Conversion of convertible notes payable 1,048,793 269,085
Cashless exercise of warrants and options $ 20,563
v3.24.3
NATURE OF OPERATIONS
9 Months Ended
Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
NATURE OF OPERATIONS

NOTE 1 – NATURE OF OPERATIONS

 

The accompanying condensed consolidated financial statements include the financial statements of Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.) (referred to herein as “Idaho Copper”). Idaho Copper is hereinafter referred to as the “Company,” “we” and “us.”

 

On February 3, 2022, the Company consummated the transactions contemplated by the Stock Purchase Agreement dated as of January 31, 2022 (the “Purchase Agreement”), by and among the Company, Crystal Globe Limited, a company incorporated under the laws of British Virgin Islands (the “Seller”), and JHP Holdings, Inc., a Nevada corporation (the “Buyer”), pursuant to which the Buyer purchased 16,644,820 shares of common stock of the Company from the Seller.

 

On January 23, 2023, the Company entered into and consummated the transactions contemplated by a share exchange agreement (the “Share Exchange Agreement”) by and among the Company, International CuMo Mining Corporation, an Idaho corporation (“ICUMO”), and all of the shareholders of ICUMO (collectively, the “ICUMO Shareholders”). Pursuant to the terms of the Share Exchange Agreement (the “RTO”), the ICUMO Shareholders transferred all the issued and outstanding shares of common stock of ICUMO to the Company in exchange for 182,240,000 shares of the Company’s common stock, par value $0.001 per share. As a result of this share exchange (the “Exchange”), ICUMO became a wholly owned subsidiary of the Company. See Note 7. For financial reporting purposes, the acquisition of ICUMO and the change of control in connection with the acquisition represented a “reverse merger” and ICUMO is deemed to be the accounting acquirer in the transaction. ICUMO is the acquirer for financial reporting purposes, and the Company is the acquired company. Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the acquisition are those of ICUMO.

 

The Company continues to be a “smaller reporting company,” as defined under the Exchange Act of 1934, as amended (the “Exchange Act”) following the Exchange, however, as a result of the Exchange, the Company has ceased to be a “shell company” (as such term is defined in Rule 12b-2 under the Exchange Act).

 

ICUMO Background

 

ICUMO is an exploration and development company with mineral right interests in the United States of America. ICUMO was originally incorporated under the laws of Nevada in 2005, as Mosquito Mining Corp. In 2013, the Company was moved to Idaho and the name changed to Idaho CuMo Mining Corporation. In early February 2023 the name was changed to Idaho Copper Corporation.

 

Nature of Operations

 

The Company is in the process of exploring its mineral rights interests in the United States and as of the date of these condensed consolidated financial statements, has not yet determined whether any of its mineral properties contain economically recoverable mineral reserves. Accordingly, the carrying amount of mineral right interests represents cumulative expenditures incurred to date and does not necessarily reflect present or future values. The recovery of these costs is dependent upon the discovery of economically recoverable mineral reserves and the ability of the Company to obtain the necessary financing to complete their exploration and development and to resolve any environmental, regulatory, or other constraints. Uncertainty also exists with respect to the recoverability of the carrying value of certain mineral rights interests. The ability of the Company to realize its investment in resource properties is contingent upon the resolution of the uncertainties and confirmation of the Company’s title to the mineral properties.

 

v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Oct. 31, 2024
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The Company follows the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (“US GAAP”) and has a year-end of January 31. On March 9, 2023, the Company filed with the State of Nevada for a year-end change from December 31 to January 31. The condensed consolidated financial statements are based on the balance sheets and statements of operations of ICUMO on a post-merger basis.

 

The unaudited condensed consolidated financial statements of the Company for the nine-month periods ended October 31, 2024, and 2023 have been prepared in accordance with US GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. Accordingly, they do not include all the information and footnotes required by US GAAP for complete financial statements. However, such information reflects all adjustments (consisting solely of normal recurring adjustments unless otherwise indicated), which are, in the opinion of management, necessary for the fair presentation of the financial position and the results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full fiscal year. The condensed consolidated balance sheet information as of January 31, 2024, was derived from the audited financial statements included in the Company’s financial statements as of and for the year ended January 31, 2024, included as an exhibit to the Company’s Quarterly Report on Form 10-Q for the period ended October 31, 2024, as filed with the Securities and Exchange Commission (the “SEC”). These condensed consolidated financial statements should be read in conjunction with that report.

 

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in the consolidation. The condensed consolidated financial statements included herein, are presented in accordance with US GAAP, and stated in United States dollars, and have been prepared by the Company, pursuant to the rules and regulations of the SEC.

 

 

Liquidity and Going Concern

 

We have incurred recurring losses since inception and expect to continue to incur losses as a result of legal and professional fees and our corporate general and administrative expenses. On October 31, 2024, we had $18,731 in cash. Our net loss incurred for the nine months ended October 31, 2024, was $4,432,829 and the working capital deficit was $1,497,605 on October 31, 2024. As a result, there is substantial doubt about our ability to continue as a going concern. In the event that we are unable to generate sufficient cash from our operating activities or raise additional funds, we may be required to delay, reduce or severely curtail our operations or otherwise impede our on-going business efforts, which could have a material adverse effect on our business, operating results, financial condition and long-term prospects. The Company expects to seek to obtain additional funding through increased revenues and future financing. There can be no assurance as to the availability or terms upon which such financing and capital might be available. The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern.

 

Use of Estimates

 

The preparation of condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash

 

Cash is comprised of cash balances. Cash is held at major financial institutions and is subject to credit risk to the extent that those balances exceed applicable Federal Deposit Insurance Corporation (“FDIC”) insurance amounts of $250,000. From time to time, the Company has certain cash balances, including restricted cash, that may exceed insured limits. The Company utilizes large and reputable banking institutions which it believes mitigates these risks. The Company has not experienced any losses in such accounts. As of October 31, 2024, the Company’s cash balance did not exceed the insurance limits.

 

Stock-Based Compensation

 

The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718, Compensation – Stock Compensation, and Certain Redeemable Financial Instruments. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method.

 

Fair Value of Financial Instruments

 

The book values of cash and accounts payable approximate their respective fair values due to the short-term nature of these instruments. The fair value hierarchy under US GAAP distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs).

 

The hierarchy consists of three levels

 

  Level one — Quoted market prices in active markets for identical assets or liabilities;
  Level two — Inputs other than level one inputs that are either directly or indirectly observable; and
  Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

 

Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter.

 

Net Loss Per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by FASB, ASC Topic 260, Earnings per Share. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. The Company has 53,214,479 dilutive shares (related to the convertible notes (see Note 4)) of common stock as of October 31, 2024.

 

Income Taxes

 

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and loss carryforwards and their respective tax bases.

 

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income (loss) in the years in which those temporary differences are expected to be recovered or settled.

 

The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

 

Tax benefits of uncertain tax positions are recognized only if it is more likely than not that the Company will be able to sustain a position taken on an income tax return. The Company has no liability for uncertain tax positions as of October 31, 2024. Interest and penalties, if any, related to unrecognized tax benefits would be recognized as interest expense. The Company does not have any accrued interest or penalties associated with unrecognized tax benefits, nor was any significant interest expense recognized during the nine months ended October 31, 2024.

 

 

Recently Issued and Adopted Accounting Pronouncements

 

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for convertible Instruments and Contracts in an Entity’s Own Equity, to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity. This ASU significantly changes the guidance on the issuer’s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity’s own equity so that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants which require liability treatment. ASU 2020-06 is effective for smaller reporting companies for fiscal years beginning after December 15, 2023. The Company adopted this standard on February 1, 2024. As a result, the Company derecognized $405,305 for the remaining balance of the unamortized beneficial conversion features attributable to its outstanding convertible notes payable. The Company elected to use the modified retrospective approach as of the adoption date and recognized an adjustment to the opening balance of its accumulated deficit in the amount of $405,305.

 

Convertible Debentures

 

The Company presents convertible debentures separately in its debt and equity components within the balance sheet. The fair value of a compound instrument at issuance is assigned to its respective debt and equity components. The fair value of the debt component is established first with the equity component being determined by the residual amount.

 

The Company measures the cost of equity-settled transactions with employees by reference to the fair value of the equity instruments at the date in which they are granted. Estimating fair values for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant.

 

The fair value of the Company’s stock option and warrant grants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expenses are recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

 

Unproven Mineral Right Interests

 

The Company will capitalize into intangible assets all costs, net of any recoveries, of acquiring, exploring, and evaluating an unproven mineral right interest, until the rights to which they relate are placed into production, at which time these deferred costs will be amortized over the estimated useful life of the rights upon commissioning the property, or written-off if the rights are disposed of, impaired or abandoned, when applicable.

 

Management reviews the carrying amounts of mineral rights annually or when there are indicators of impairment and will recognize impairment based upon current exploration results and upon assessment of the probability of profitable exploitation of the rights. An indication of impairment includes but is not limited to expiration of the right to explore, substantive expenditure in the specific area is neither budgeted nor planned, and if the entity has decided to discontinue exploration activity in a specific area. Management’s assessment of the mineral right’s fair value is also based upon a review of other mineral right transactions that have occurred in the same geographic area as that of the rights under review.

 

Costs will include the cash consideration and the fair value of shares issued on the acquisition of mineral rights. Rights acquired under option or joint venture agreements, whereby payments are made at the sole discretion of the Company, are not accrued and are only recorded in the accounts when the payments are made. Proceeds from property option payments received by the Company are netted against the deferred costs of the related mineral rights, with any excess being included in operations.

 

The application of the Company’s accounting policy for unproven mineral right interests requires judgment in determining whether it is likely that future economic benefits will flow to the Company, which may be based on assumptions about future events or circumstances. Estimates and assumptions may change if new information becomes available. If, after expenditures are capitalized, information becomes available suggesting that the recovery of the expenditures is unlikely, the amount capitalized is impaired with a corresponding charge to profit or loss in the period in which the new information becomes available.

 

There may be material uncertainties associated with the Company’s title and ownership of its unproven mineral right interests. Ordinarily the Company does not own the land upon which an interest is located, and title may be subject to unregistered prior agreements or transfers or other undetected defects.

 

Impairment of Long-Lived Assets

 

The Company’s future long-lived assets and other assets (consisting of property and equipment) will be reviewed for impairment in accordance with the guidance of the FASB ASC Topic 360-10, Property, Plant, and Equipment. Long lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used are measured by a comparison of the carrying amount of an asset to the undiscounted future net cash flows expected to be generated by that asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.

 

Reclamation Provision

 

An obligation to incur restoration, rehabilitation and environmental costs arises when environmental disturbance is caused by the exploration, development, or ongoing production of a mineral property interest. Such costs arising from the decommissioning of plant and other site preparation work, discounted to their net present value, are provided and capitalized at the start of each project to the carrying amount of the asset, as soon as the obligation to incur such costs arises. Discount rates using a pre-tax rate that reflect the time value of money are used to calculate the net present value. These costs are charged against profit or loss over the economic life of the related asset, through amortization using either the unit-of-production or straight-line method. The related liability is adjusted for each period for the unwinding of the discount rate and for changes to the current market-based discount rate, amount or timing of the underlying cash flows needed to settle the obligation. Costs for restoration of subsequent site damage which is created on an ongoing basis during production are provided for at their net present values and charged against profits as extraction progresses. As of October 31, 2024, there are no costs as production has not yet commenced.

 

 

Related Party Transactions

 

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or significant common influence, related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. Related party transactions that are in the normal course of business and have commercial substance are measured at the exchange amount, which is determined on a cost recovery basis.

 

 

Stock Purchase Warrants

 

The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity. We determine the accounting classification of warrants we issue, as either liability or equity classified, by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity, then in accordance with ASC 815-40, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock. Under ASC 480, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate us to settle the warrants or the underlying shares by paying cash or other assets, and warrants that must or may require settlement by issuing variable number of shares. If warrants do not meet the liability classification under ASC 480-10, we assess the requirements under ASC 815-40, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature.

 

If the warrants do not require liability classification under ASC 815-40, in order to conclude equity classification, we also assess whether the warrants are indexed to our common stock and whether the warrants are classified as equity under ASC 815-40 or other US GAAP. After all such assessments, we conclude whether the warrants are classified as liability or equity. Liability classified warrants require fair value accounting at issuance and subsequent to initial issuance with all changes in fair value after the issuance date recorded in the statements of operations. Equity classified warrants only require fair value accounting at issuance with no changes recognized subsequent to the issuance date.

 

v3.24.3
RECLAMATION BONDS AND PROVISIONS
9 Months Ended
Oct. 31, 2024
Reclamation Bonds And Provisions  
RECLAMATION BONDS AND PROVISIONS

NOTE 3 – RECLAMATION BONDS AND PROVISIONS

 

Reclamation Bonds and Provisions

 

During 2016, the Company entered into a surety agreement that guarantees the reclamation bond on the CuMo Property. In order to maintain the good standing of this surety, the Company is required to make an annual payment of $8,340. The Company has a deposit of $100,000 (as reflected in Deposit on the balance sheet) for the reclamation bond which has a face value of $278,000 as determined by the United States Department of Agriculture Forest Service.

 

The security deposit is refundable when the Company completes the required reclamation clean-up costs.

 

 

v3.24.3
CONVERTIBLE NOTES
9 Months Ended
Oct. 31, 2024
Debt Disclosure [Abstract]  
CONVERTIBLE NOTES

NOTE 4 – CONVERTIBLE NOTES

 

The Company has $0 and $1,100,200 in convertible secured notes payable at October 31, 2024, and January 31, 2024. The balances as of January 31, 2024 were as follows:

 

          Issue  Maturity  Conversion   Conversion   Warrants   Exercise   Warrant
   Balance   Collateral  Date  Date  Price   Shares   Shares   Price   Expiration
Steven Rudofsky  $125,000   (a)  1/23/23  7/23/25  $0.10    1,250,000    1,250,000   $0.15   1/23/28
Feehan Partners, LP  $87,334   (a)  1/23/23  7/23/25  $0.10    873,340    873,340   $0.15   1/23/28
The Jeffrey V. and Karin R. Hembrock Revocable Trust  $100,000   (a)  1/23/23  7/23/25  $0.10    1,000,000    1,000,000   $0.15   1/23/28
The Gaitonde Living Trust, Girish Gaitonde Trustee  $100,000   (a)  1/23/23  7/23/25  $0.10    1,000,000    1,000,000   $0.15   1/23/28
Corey Redfield  $50,000   (a)  1/23/23  7/23/25  $0.10    500,000    500,000   $0.15   1/23/28
PV Partners, LP  $75,000   (a)  1/23/23  7/23/25  $0.10    750,000    750,000   $0.15   1/23/28
Shaun Dykes  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Patricia Czerniej  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
James Dykes  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Jason Czerniej  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Louise Dykes  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Andrew Brodkey  $98,000   (a)  1/23/23  7/23/25  $0.10    980,000    980,000   $0.15   1/23/28
Feehan Partners, LP  $112,666   (a)  1/23/23  7/23/25  $0.10    1,126,660    1,126,660   $0.15   1/23/28
Gil Atzmon  $102,200   (a)  5/8/23  11/8/25  $0.23    440,000    550,000   $0.23   5/8/26
Jon Powell  $100,000   (a)  5/8/23  11/8/25  $0.23    434,783    543,479   $0.23   5/8/26
Total  $1,100,200                  9,854,783    10,073,479         

 

(a)The replacement notes and new warrants are secured by mining claims and rights of the CuMo Project.

 

 

As of January 31, 2024, there were debt discounts and beneficial conversion features on the above notes payable of $476,201. The Company derecognized the unamortized beneficial conversion feature upon its adoption of ASU 2020-06 as described in Note 1.

 

On April 5, 2024, holders of $1,099,200 par value of Convertible Secured Notes issued between December 2022 and May 2023 elected to convert those notes to common stock under contract terms. As a result, we issued 9,854,783 shares of common stock to the respective holders.

 

v3.24.3
BOND LIABILITIES
9 Months Ended
Oct. 31, 2024
Other Liabilities Disclosure [Abstract]  
BOND LIABILITIES

NOTE 5 – BOND LIABILITIES

 

The Company has bond liabilities as of October 31, 2024, as follows:

 

   Principal Amount   Interest Rate   Note Date  Maturity Date  Collateral   Origination   Features 
Yin Yin Silver Limited  $500,000    8.50%  8/4/15  8/4/2025   (1)   (2)   (5)
Yin Yin Silver Limited  $500,000    8.50%  10/28/16  10/28/2026   (1)   (2)   (5)
Yin Yin Silver Limited  $250,000    8.50%  12/27/17  12/27/2024   (1)   (2)   (5)
Barry Swenson  $500,000    8.50%  12/31/17  12/31/2025   (1)   (2)   (5)
Don H. Adair or Joanne Adair  $125,000    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Joseph Swinford or Danielle Swinford  $50,000    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Brandon Swain or Sierra Swain  $50,000    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Scott Collins or Kendra Collins  $12,500    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Carl Collins or Ellen Collins  $12,500    8.50%  2/15/17  2/15/2024   (1)   (3)   (6)
Jim Hammerel  $5,000    8.50%  9/21/2017  9/21/2024   (1)   (2)   (5)
Bret Renaud  $5,000    8.50%  10/14/2017  10/14/2024   (1)   (2)   (5)
Elatam Group Ltd  $67,000    7.50%  8/24/2021  5/31/2028   (1)   (2)   (6)
James Hardy  $7,000    7.50%  8/24/2021  5/31/2028   (1)   (2)   (6)
Acepac Holdings  $1,000,000    7.50%  8/24/2021  5/31/2028   (1)   (4)   (6)
Rick Ward  $15,000    7.50%  8/24/2021  5/31/2028   (1)   (2)   (6)
Robert & Joan Sweetman  $10,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Michael Swenson  $10,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Connie Sun  $3,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Elizabeth Enoch  $10,000    8.00%  8/1/2018  7/1/2025   (1)   (2)   (6)
William C. Stanton and Carol Stanton  $3,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Total  $3,135,000                           

 

  (1) All notes above are secured by the following collateral: all the assets of Idaho CuMo except for the following patented lode mining claims located in Section 13, Township 8 North, Range 5 East, Boise Meridian, Boise County, Idaho, as depicted on Mineral Survey 1706: (i) Blackbird, (ii) Red Flag, (iii) Enterprise, (iv) Enterprise Fraction, (v) Commonwealth, (vi) Baby Mine. Each Note will rank pari passu with all other Notes.
  (2) Financial investment by accredited investor.
  (3) Issued in exchange for 20 unpatented mining claims located approximately 10 miles northeast of Pioneerville, Idaho.
  (4) Issued to settle litigation between MultiMetal Development Ltd. (former parent company of Idaho Copper Corp) and Acepac Holdings.
  (5) Interest capitalized; accrual dates 6/30 and 12/31.
  (6) Interest paid in cash on 6/30 and 12/31.
  (7) On September 25, 2023, these notes were extended from February 15, 2024, to February 15, 2025. The extension was analyzed for modification versus extinguishment and was determined to be a modification.

 

 

v3.24.3
RELATED PARTY TRANSACTIONS
9 Months Ended
Oct. 31, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 6 – RELATED PARTY TRANSACTIONS

 

As of October 31, 2024, the Company has accrued compensation of $388,971 for its officers as recorded in accrued expenses to related parties. The Company compensated its officers $858,500 for the nine months ended October 31, 2024.

 

On January 23, 2023, the Company issued convertible notes payable to the following: Steven Rudofsky (“Rudofsky”), former Chairman and CEO, for $125,000; Feehan Partners LP (“Feehan”), controlled by Robert Scannell (“Scannell”), CFO and Director, for $87,334 and $112,666; Andrew Brodkey (“Brodkey”). CEO, COO and Director, for $98,000; and Shaun Dykes (“Dykes”), Vice President and Director, for $150,000 (issued to Dykes and related parties to Dykes). On April 5, 2024, Rudofsky, Feehan, Brodkey, and Dykes converted notes payable of $125,000, $200,000, $98,000, and $30,000, respectively, into 1,666,667, 2,666,666, 1,306,667, and 400,000 shares of common stock, respectively (see Note 4).

 

On April 3, 2024, the officers of the company, Rudofsky, Brodkey, and Scannell each elected to exercise 5,360,000 vested stock options with a strike price of $0.125 and an expiration date of September 30, 2027. All options were exercised on a cashless basis, resulting in the issuance of 3,385,000 shares per officer, or a total of 11,055,000 common shares.

 

On April 4, 2024, Feehan and Brodkey executed cashless conversion of 2,666,666 and 1,306,667 warrants, respectively, into 1,666,666 and 816,666 shares of common stock, respectively.

 

On April 6, 2024, Dykes executed cashless conversion of 400,000 warrants into 251,250 shares of common stock.

 

On April 8, 2024, Rudofsky executed cashless conversion of 1,666,667 warrants into 1,041,667 shares of common stock.

 

On May 1, 2024, Rudofsky, Brodkey, and Scannell each elected to convert accrued compensation of $31,250, $17,500, and $62,500, respectively, into 195,313, 109,375, and 390,625 shares of common stock, respectively.

 

On August 2, 2024, Brodkey, Rudofsky, and Scannell each elected to convert accrued compensation of $42,500, $31,250, and $87,500, respectively, into 170,000, 125,000, and 350,000 shares of common stock, respectively.

 

On September 25, 2024, the Company issued stock incentives to Brodkey (2,570,000 shares valued at $565,400), Scannell (2,500,000 shares valued at $550,000), and Rudofsky (125,000 shares valued at $27,500).

 

As of October 31, 2024, the Company has payables of $54,000 to Brodkey.

 

v3.24.3
STOCKHOLDERS’ EQUITY
9 Months Ended
Oct. 31, 2024
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 7 – STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

The Company has authorized share capital of 10,000,000 shares of preferred stock with par value of $0.001.

 

On January 12, 2024, we entered into Unit Subscription Purchase Agreements (“Subscription Agreements”) with purchasers for an aggregate of 23 (“Units”) at a price of $12,000 per Unit. Each Unit comprised of one (1) share of Series A Convertible Non-Voting Preferred Stock, $0.001 par value per share (the “Series A Preferred Stock”), and (ii) 62,500 common stock purchase warrants (the “Warrants”). The rights and preferences of the Series A Preferred Stock, include without limitation, the right of each holder thereof to convert each share of Series A Preferred Stock into 50,000 shares of the Company’s common stock, par value $0.001 par value per share (“Common Stock”), as set forth in the Certificate of Designation of Series A Convertible Non-Voting Preferred Stock (the “Certificate of Designation”). The Warrant holders have the right to exercise the Warrants for three (3) years at an exercise price of $0.24 per share of Common Stock. The Units were offered and sold in reliance upon exemptions from the registration requirements provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) of Regulation D promulgated thereunder. The Company has agreed to file a registration statement to cover the re-sale of the shares of Common Stock issuable upon the conversion of the Series A Preferred Stock, and upon the exercise of the Warrants. The Company intends to utilize the net proceeds from the sale of the Units in the Offering for working capital and general corporate purposes.

 

The warrants issued through January 31, 2024, had a Black-Scholes fair value of $156,746 for the 1,125,000 warrants issued.

 

Stock price  $ 0.070.20 
Exercise price  $0.24 
Expected volatility   521 -1,042%
Expected term (years)   3 
Risk free rate   4.054.45%
Dividends   0%

 

Between February and October 2024, we entered into subscription agreements (each a “Subscription Agreement”) with certain accredited investors (each, a “Subscriber” and collectively, the “Subscribers”), pursuant to which the Company offered and sold to the Subscribers in a private placement offering (the “Offering”), units (each, a “Unit” and, collectively, the “Units”), for a purchase price of $12,000 per Unit, for gross proceeds of $1,964,000. Each Unit consists of one (1) share of the Company’s Series A Convertible Non-Voting Preferred Stock, par value $0.001 per share (the “Preferred Stock”), and (ii) 62,500 common stock purchase warrants (the “Warrants”). Each share of Preferred Stock converts into 50,000 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”). The Warrant entitles the holders to shares of Common Stock for three (3) years, at an exercise price of $0.24 per share.

 

 

As of October 31, 2024, and January 31, 2024, the Company had 186.67 and 23 shares of Series A Preferred Stock issued and outstanding, respectively.

 

Common Stock

 

The Company has authorized share capital consisted of 500,000,000 shares of common stock with par value of $0.001.

 

As described in Note 4, the Company issued certain shares of its common stock for the conversion of convertible notes payable during the period ended October 31, 2024.

 

As described in Note 6, the Company issued certain shares of its common stock to related parties during the period ended October 31, 2024.

 

On May 1, 2024, Rudofsky, Brodkey, and Scannell each elected to convert accrued compensation of $31,250, $17,500, and $62,500, respectively, into 195,313, 109,375, and 390,625 shares of common stock, respectively.

 

During May 2024, the Company issued 1,041,667 shares of common stock to an officer as a result of the cashless exercise of their warrants.

 

On August 2, 2024, Brodkey, Rudofsky, and Scannell each elected to convert accrued compensation of $42,500, $31,250, and $87,500, respectively, into 170,000, 125,000, and 350,000 shares of common stock, respectively. Other employees and non-employees converted compensation of $574,750 into 439,000 shares of common stock.

 

On September 25, 2024, the Company issued stock incentives to Brodkey (2,570,000 shares valued at $565,400), Scannell (2,500,000 shares valued at $550,000), and Rudofsky (125,000 shares valued at $27,500). The Company also issued stock incentives to employees and non-employees (375,000 shares valued at $82,500).

 

For the nine months ended October 31, 2024, the Company issued 1,039,096 shares of common stock for non-officer services.

 

As of October 31, 2024, the Company had 256,942,937 shares issued, issuable, and outstanding.

 

Options

 

On January 23, 2023, as part of the RTO, the Company accepted the assignment of the stock options for common stock from ICUMO to the Company, as consented by the parties. The Company has 56,615,000 options issued to various officers, directors, and employees, based on milestones. As of January 31, 2024, and October 31, 2024, 22,646,000 and 6,566,000 options are vested. The exercise price for the options is $0.125 and they expire on December 31, 2027. The Company recognized $189,248 the period ended October 31, 2024, in stock-based compensation expense related to the estimated vesting of these options. As of October 31, 2024, none of the remaining milestones necessary for these options to vest have been met. The remaining additional compensation to be recognized as these options vest is approximately $568,000 during fiscal 2025 based on the current estimated time to reach the milestones.

 

The remaining vesting milestones required to be met are (1) obtaining an updated PEA, (2) an uplist of the Company’s common stock to a national exchange and (3) the successful raising of $5 million or more in new capital. Each of these milestones vest an additional 20% of the options upon being met and were estimated to have a 50% probability of being met as of January 31, 2024. Management reviews the estimate of meeting each probability as well as the related timing at each reporting period.

 

On April 3, 2024, Brodkey, Scannell, Rudofsky, and Dykes executed cashless conversions of 5,360,000 vested options each into 3,685,000 shares of common stock each.

 

Warrants

 

On April 4, 2024, Feehan and Brodkey executed cashless conversion of 2,666,666 and 1,306,667 warrants, respectively, into 1,666,666 and 816,666 shares of common stock, respectively.

 

On April 6, 2024, Dykes executed cashless conversion of 400,000 warrants into 251,250 shares of common stock.

 

On April 6, 2024, four warrant holders executed cashless conversion of 1,200,000 warrants into 753,750 shares of common stock.

 

On April 8, 2024, Rudofsky executed cashless conversion of 1,666,667 warrants into 1,041,667 shares of common stock.

 

As of October 31, 2024, the Company had 2,614,783 warrants outstanding with an exercise price of $0.15, which relate to the convertible notes dated January 23, 2023 (see Note 4), and 1,093,479 warrants outstanding with an exercise price of $0.23, which relate to the convertible notes dated May 8, 2023 (see Note 4).

 

Stock-based Compensation Expense

 

The Company recognizes stock-based compensation using the straight-line method over the requisite service period or derived service period. The Company recognized stock-based compensation for the three months ended October 31, 2024, and 2023 of $1,704,024 and $0, respectively, and for the nine months ended October 31, 2024, and 2023 of $2,258,080 and $140,739, respectively.

 

v3.24.3
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

The Company is subject, from time to time, to claims by third parties under various legal disputes. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on the Company’s liquidity, financial condition and cash flows.

 

Certain conditions may exist as of the date the condensed consolidated financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s condensed consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the nature of the guarantee would be disclosed.

 

The Company entered into a new long-term lease agreement for warehouse space in Idaho. The lease began on April 1, 2024, with an initial period of 3 years and an optional 3-year renewal at the end of the initial term. The Company may cancel the lease at any time after 13 months from the effective date of the lease by providing a 3-month notice of cancellation. The base lease payment is $3,600 through January 1, 2026, at which point base rent increases to $3,700 until January 1, 2027, at which point it increases to $3,800 until January 1, 2028, at which point it increases to $3,900. Prior to entering into this lease agreement, the Company was a party to a month-to-month lease which it had not terminated. The lessor and the Company agreed regain access to the warehouse including obtaining access to the Company’s property contained within such warehouse, the lessor agreed to the following additional payments. A single payment of $100,000 which was paid on March 5, 2024, and $6,000 per month beginning May 1, 2024, and ending on February 1, 2025.

 

Initially, the Company measure the right of use asset and liability associated with its office lease using the following inputs:

 

Remaining lease term (in years)   1.08 
Discount rate   12%

 

The remaining term of the lease was based on the amount of time left before the Company may exercise its right to cancel the lease which is 13 months.

 

The Company considered whether it was probable it would exercise and extend beyond the initial 3-year term and determine it was not probable that the Company would exercise this renewal option.

 

The Company records rent on straight-line basis over the terms of the underlying lease. Estimated future minimum lease payments under the lease are as follows:

 

Year Ending January 31,  Amount 
2025  $43,200 
Total remaining lease payments   43,200 
Less: imputed interest   22,357 
Present value of remaining lease payments  $20,843 

 

The rent expense for the nine months October 31, 2024, and 2023 was $143,085 and $21,000 respectively.

 

v3.24.3
INCOME TAXES
9 Months Ended
Oct. 31, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 9 – INCOME TAXES

 

As of October 31, 2024, and January 31, 2024, the Company has net operating loss carry forwards of $1,312,283 and $751,916, respectively, which may be available to reduce future years’ taxable income through 2043. The Company’s net operating loss carry forwards may be subject to annual limitations, which could reduce or defer the utilization of the losses as a result of an ownership change as defined in Section 382 of the Internal Revenue Code.

 

The Company’s tax expense differs from the “expected” tax expense for Federal income tax purposes (computed by applying the United States Federal tax rate of 21% and state rate of 5% to loss before taxes for fiscal years 2025 and 2024), as follows:

 

   October 31,   January 31, 
   2024   2024 
Tax expense (benefit) at the statutory rate  $(452,604)  $(285,980)
State income taxes, net of federal income tax benefit   (107,763)   (68,090)
Change in valuation allowance   560,367    354,070 
Total  $-   $- 

 

The tax effects of the temporary differences between reportable financial statement income and taxable income are recognized as deferred tax assets and liabilities.

 

The tax year 2023 remains open for examination by federal agencies and other jurisdictions in which it operates.

 

The tax effect of significant components of the Company’s deferred tax assets and liabilities at October 31, 2024 and January 31, 2024 are as follows:

 

   October 31, 2024   January 31, 2024 
Deferred tax assets:          
Net operating loss carryforward  $1,312,283   $751,916 
Timing differences   -    - 
Total gross deferred tax assets   1,312,283    751,916 
Less: Deferred tax asset valuation allowance   (1,312,283)   (751,916)
Total net deferred taxes  $-   $- 

 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.

 

 

Because of the historical earnings history of the Company, the net deferred tax assets for 2023 were fully offset by a 100% valuation allowance. The valuation allowance for the remaining net deferred tax assets was $1,312,283 and $751,916 as of October 31, 2024, and January 31,2024, respectively.

 

v3.24.3
SUBSEQUENT EVENTS
9 Months Ended
Oct. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 10 – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events from the condensed consolidated balance sheet through the date of this filing and determined there were no events to disclose or that require recognition in the accompanying condensed consolidated financial statements.

 

On November 4, 2024, the Company issued a secured promissory note for $25,000 to Feehan. The note accrues interest at 10% and is due on November 4, 2025.

 

On November 5, 2024, Brodkey and Scannell each elected to convert accrued compensation of $42,500 and $87,500, respectively, into 193,182 and 397,727 shares of common stock, respectively. Other employees and non-employees converted compensation of $67,500 into 306,818 shares of common stock.

 

On November 5, 2024, Rudofsky exercised 500,000 warrants with a $0.15 exercise price into 500,000 shares of common stock for $75,000.

 

Offering

 

The Company filed a registration statement on Form S-1 with the Securities and Exchange Commission (“SEC”) on July 11, 2024, to offer and resell up to 94,126,642 shares of common stock by selling stockholders consisting of (i) up to 9,283,333 shares of common stock issuable upon the conversion of 185.66 shares of Series A Convertible Non-Voting Preferred Stock, $0.001 par value per share sold in a private placement offering with Newbridge Securities Corporation acting as the sole placement agent (the “Newbridge Private Placement Offering”) (ii) up to 11,604,167 shares of common stock issuable upon the exercise of warrants sold in the Newbridge Private Placement Offering, (iii) 813,333 shares of common stock issued to the placement agent of the Newbridge Private Placement Offering, (iv) 66,794,143 shares of common stock issued pursuant to the January 23, 2023 share exchange with the former shareholders of ICUMO, (v) 4,333,333 shares of common stock sold a private placement offering on December 15, 2022, (vi) 880,000 shares of common stock issuable upon conversion of the principal and accrued interest of two convertible promissory notes in the aggregate principal amount of $201,200 in total, at a price of $0.23 per share, issued to certain selling stockholders on April 5, 2024, and (vii) 418,333 shares of common stock issued in consideration of consulting fees to various consultants.

 

The registration statement has not yet been declared effective by the SEC.

v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Oct. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The Company follows the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (“US GAAP”) and has a year-end of January 31. On March 9, 2023, the Company filed with the State of Nevada for a year-end change from December 31 to January 31. The condensed consolidated financial statements are based on the balance sheets and statements of operations of ICUMO on a post-merger basis.

 

The unaudited condensed consolidated financial statements of the Company for the nine-month periods ended October 31, 2024, and 2023 have been prepared in accordance with US GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. Accordingly, they do not include all the information and footnotes required by US GAAP for complete financial statements. However, such information reflects all adjustments (consisting solely of normal recurring adjustments unless otherwise indicated), which are, in the opinion of management, necessary for the fair presentation of the financial position and the results of operations. Results shown for interim periods are not necessarily indicative of the results to be obtained for a full fiscal year. The condensed consolidated balance sheet information as of January 31, 2024, was derived from the audited financial statements included in the Company’s financial statements as of and for the year ended January 31, 2024, included as an exhibit to the Company’s Quarterly Report on Form 10-Q for the period ended October 31, 2024, as filed with the Securities and Exchange Commission (the “SEC”). These condensed consolidated financial statements should be read in conjunction with that report.

 

Principles of Consolidation

Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in the consolidation. The condensed consolidated financial statements included herein, are presented in accordance with US GAAP, and stated in United States dollars, and have been prepared by the Company, pursuant to the rules and regulations of the SEC.

 

 

Liquidity and Going Concern

Liquidity and Going Concern

 

We have incurred recurring losses since inception and expect to continue to incur losses as a result of legal and professional fees and our corporate general and administrative expenses. On October 31, 2024, we had $18,731 in cash. Our net loss incurred for the nine months ended October 31, 2024, was $4,432,829 and the working capital deficit was $1,497,605 on October 31, 2024. As a result, there is substantial doubt about our ability to continue as a going concern. In the event that we are unable to generate sufficient cash from our operating activities or raise additional funds, we may be required to delay, reduce or severely curtail our operations or otherwise impede our on-going business efforts, which could have a material adverse effect on our business, operating results, financial condition and long-term prospects. The Company expects to seek to obtain additional funding through increased revenues and future financing. There can be no assurance as to the availability or terms upon which such financing and capital might be available. The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern.

 

Use of Estimates

Use of Estimates

 

The preparation of condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash

Cash

 

Cash is comprised of cash balances. Cash is held at major financial institutions and is subject to credit risk to the extent that those balances exceed applicable Federal Deposit Insurance Corporation (“FDIC”) insurance amounts of $250,000. From time to time, the Company has certain cash balances, including restricted cash, that may exceed insured limits. The Company utilizes large and reputable banking institutions which it believes mitigates these risks. The Company has not experienced any losses in such accounts. As of October 31, 2024, the Company’s cash balance did not exceed the insurance limits.

 

Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for stock-based instruments issued to employees in accordance with ASC Topic 718, Compensation – Stock Compensation, and Certain Redeemable Financial Instruments. Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718 requires companies to recognize in the statement of operations the grant-date fair value of stock options and other equity-based compensation issued to employees. The value of the portion of an award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The book values of cash and accounts payable approximate their respective fair values due to the short-term nature of these instruments. The fair value hierarchy under US GAAP distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs).

 

The hierarchy consists of three levels

 

  Level one — Quoted market prices in active markets for identical assets or liabilities;
  Level two — Inputs other than level one inputs that are either directly or indirectly observable; and
  Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

 

Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter.

 

Net Loss Per Share

Net Loss Per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by FASB, ASC Topic 260, Earnings per Share. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. The Company has 53,214,479 dilutive shares (related to the convertible notes (see Note 4)) of common stock as of October 31, 2024.

 

Income Taxes

Income Taxes

 

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and loss carryforwards and their respective tax bases.

 

Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income (loss) in the years in which those temporary differences are expected to be recovered or settled.

 

The effect of a change in tax rules on deferred tax assets and liabilities is recognized in operations in the year of change. A valuation allowance is recorded when it is “more likely-than-not” that a deferred tax asset will not be realized.

 

Tax benefits of uncertain tax positions are recognized only if it is more likely than not that the Company will be able to sustain a position taken on an income tax return. The Company has no liability for uncertain tax positions as of October 31, 2024. Interest and penalties, if any, related to unrecognized tax benefits would be recognized as interest expense. The Company does not have any accrued interest or penalties associated with unrecognized tax benefits, nor was any significant interest expense recognized during the nine months ended October 31, 2024.

 

 

Recently Issued and Adopted Accounting Pronouncements

Recently Issued and Adopted Accounting Pronouncements

 

In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for convertible Instruments and Contracts in an Entity’s Own Equity, to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity. This ASU significantly changes the guidance on the issuer’s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity’s own equity so that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants which require liability treatment. ASU 2020-06 is effective for smaller reporting companies for fiscal years beginning after December 15, 2023. The Company adopted this standard on February 1, 2024. As a result, the Company derecognized $405,305 for the remaining balance of the unamortized beneficial conversion features attributable to its outstanding convertible notes payable. The Company elected to use the modified retrospective approach as of the adoption date and recognized an adjustment to the opening balance of its accumulated deficit in the amount of $405,305.

 

Convertible Debentures

Convertible Debentures

 

The Company presents convertible debentures separately in its debt and equity components within the balance sheet. The fair value of a compound instrument at issuance is assigned to its respective debt and equity components. The fair value of the debt component is established first with the equity component being determined by the residual amount.

 

The Company measures the cost of equity-settled transactions with employees by reference to the fair value of the equity instruments at the date in which they are granted. Estimating fair values for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant.

 

The fair value of the Company’s stock option and warrant grants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expenses are recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

 

Unproven Mineral Right Interests

Unproven Mineral Right Interests

 

The Company will capitalize into intangible assets all costs, net of any recoveries, of acquiring, exploring, and evaluating an unproven mineral right interest, until the rights to which they relate are placed into production, at which time these deferred costs will be amortized over the estimated useful life of the rights upon commissioning the property, or written-off if the rights are disposed of, impaired or abandoned, when applicable.

 

Management reviews the carrying amounts of mineral rights annually or when there are indicators of impairment and will recognize impairment based upon current exploration results and upon assessment of the probability of profitable exploitation of the rights. An indication of impairment includes but is not limited to expiration of the right to explore, substantive expenditure in the specific area is neither budgeted nor planned, and if the entity has decided to discontinue exploration activity in a specific area. Management’s assessment of the mineral right’s fair value is also based upon a review of other mineral right transactions that have occurred in the same geographic area as that of the rights under review.

 

Costs will include the cash consideration and the fair value of shares issued on the acquisition of mineral rights. Rights acquired under option or joint venture agreements, whereby payments are made at the sole discretion of the Company, are not accrued and are only recorded in the accounts when the payments are made. Proceeds from property option payments received by the Company are netted against the deferred costs of the related mineral rights, with any excess being included in operations.

 

The application of the Company’s accounting policy for unproven mineral right interests requires judgment in determining whether it is likely that future economic benefits will flow to the Company, which may be based on assumptions about future events or circumstances. Estimates and assumptions may change if new information becomes available. If, after expenditures are capitalized, information becomes available suggesting that the recovery of the expenditures is unlikely, the amount capitalized is impaired with a corresponding charge to profit or loss in the period in which the new information becomes available.

 

There may be material uncertainties associated with the Company’s title and ownership of its unproven mineral right interests. Ordinarily the Company does not own the land upon which an interest is located, and title may be subject to unregistered prior agreements or transfers or other undetected defects.

 

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

The Company’s future long-lived assets and other assets (consisting of property and equipment) will be reviewed for impairment in accordance with the guidance of the FASB ASC Topic 360-10, Property, Plant, and Equipment. Long lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used are measured by a comparison of the carrying amount of an asset to the undiscounted future net cash flows expected to be generated by that asset. If the carrying amount of an asset exceeds its estimated future undiscounted cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.

 

Reclamation Provision

Reclamation Provision

 

An obligation to incur restoration, rehabilitation and environmental costs arises when environmental disturbance is caused by the exploration, development, or ongoing production of a mineral property interest. Such costs arising from the decommissioning of plant and other site preparation work, discounted to their net present value, are provided and capitalized at the start of each project to the carrying amount of the asset, as soon as the obligation to incur such costs arises. Discount rates using a pre-tax rate that reflect the time value of money are used to calculate the net present value. These costs are charged against profit or loss over the economic life of the related asset, through amortization using either the unit-of-production or straight-line method. The related liability is adjusted for each period for the unwinding of the discount rate and for changes to the current market-based discount rate, amount or timing of the underlying cash flows needed to settle the obligation. Costs for restoration of subsequent site damage which is created on an ongoing basis during production are provided for at their net present values and charged against profits as extraction progresses. As of October 31, 2024, there are no costs as production has not yet commenced.

 

 

Related Party Transactions

Related Party Transactions

 

Parties are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Parties are also considered to be related if they are subject to common control or significant common influence, related parties may be individuals or corporate entities. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties. Related party transactions that are in the normal course of business and have commercial substance are measured at the exchange amount, which is determined on a cost recovery basis.

 

 

Stock Purchase Warrants

Stock Purchase Warrants

 

The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity. We determine the accounting classification of warrants we issue, as either liability or equity classified, by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity, then in accordance with ASC 815-40, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock. Under ASC 480, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate us to settle the warrants or the underlying shares by paying cash or other assets, and warrants that must or may require settlement by issuing variable number of shares. If warrants do not meet the liability classification under ASC 480-10, we assess the requirements under ASC 815-40, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature.

 

If the warrants do not require liability classification under ASC 815-40, in order to conclude equity classification, we also assess whether the warrants are indexed to our common stock and whether the warrants are classified as equity under ASC 815-40 or other US GAAP. After all such assessments, we conclude whether the warrants are classified as liability or equity. Liability classified warrants require fair value accounting at issuance and subsequent to initial issuance with all changes in fair value after the issuance date recorded in the statements of operations. Equity classified warrants only require fair value accounting at issuance with no changes recognized subsequent to the issuance date.

 

v3.24.3
CONVERTIBLE NOTES (Tables)
9 Months Ended
Oct. 31, 2024
Debt Disclosure [Abstract]  
SCHEDULE OF CONVERTIBLE SECURED NOTES PAYABLE

 

          Issue  Maturity  Conversion   Conversion   Warrants   Exercise   Warrant
   Balance   Collateral  Date  Date  Price   Shares   Shares   Price   Expiration
Steven Rudofsky  $125,000   (a)  1/23/23  7/23/25  $0.10    1,250,000    1,250,000   $0.15   1/23/28
Feehan Partners, LP  $87,334   (a)  1/23/23  7/23/25  $0.10    873,340    873,340   $0.15   1/23/28
The Jeffrey V. and Karin R. Hembrock Revocable Trust  $100,000   (a)  1/23/23  7/23/25  $0.10    1,000,000    1,000,000   $0.15   1/23/28
The Gaitonde Living Trust, Girish Gaitonde Trustee  $100,000   (a)  1/23/23  7/23/25  $0.10    1,000,000    1,000,000   $0.15   1/23/28
Corey Redfield  $50,000   (a)  1/23/23  7/23/25  $0.10    500,000    500,000   $0.15   1/23/28
PV Partners, LP  $75,000   (a)  1/23/23  7/23/25  $0.10    750,000    750,000   $0.15   1/23/28
Shaun Dykes  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Patricia Czerniej  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
James Dykes  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Jason Czerniej  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Louise Dykes  $30,000   (a)  1/23/23  7/23/25  $0.10    300,000    300,000   $0.15   1/23/28
Andrew Brodkey  $98,000   (a)  1/23/23  7/23/25  $0.10    980,000    980,000   $0.15   1/23/28
Feehan Partners, LP  $112,666   (a)  1/23/23  7/23/25  $0.10    1,126,660    1,126,660   $0.15   1/23/28
Gil Atzmon  $102,200   (a)  5/8/23  11/8/25  $0.23    440,000    550,000   $0.23   5/8/26
Jon Powell  $100,000   (a)  5/8/23  11/8/25  $0.23    434,783    543,479   $0.23   5/8/26
Total  $1,100,200                  9,854,783    10,073,479         

 

(a)The replacement notes and new warrants are secured by mining claims and rights of the CuMo Project.
v3.24.3
BOND LIABILITIES (Tables)
9 Months Ended
Oct. 31, 2024
Other Liabilities Disclosure [Abstract]  
SCHEDULE OF BOND LIABILITIES

The Company has bond liabilities as of October 31, 2024, as follows:

 

   Principal Amount   Interest Rate   Note Date  Maturity Date  Collateral   Origination   Features 
Yin Yin Silver Limited  $500,000    8.50%  8/4/15  8/4/2025   (1)   (2)   (5)
Yin Yin Silver Limited  $500,000    8.50%  10/28/16  10/28/2026   (1)   (2)   (5)
Yin Yin Silver Limited  $250,000    8.50%  12/27/17  12/27/2024   (1)   (2)   (5)
Barry Swenson  $500,000    8.50%  12/31/17  12/31/2025   (1)   (2)   (5)
Don H. Adair or Joanne Adair  $125,000    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Joseph Swinford or Danielle Swinford  $50,000    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Brandon Swain or Sierra Swain  $50,000    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Scott Collins or Kendra Collins  $12,500    8.50%  2/15/17  2/15/2024   (1)   (3)   (6) (7)
Carl Collins or Ellen Collins  $12,500    8.50%  2/15/17  2/15/2024   (1)   (3)   (6)
Jim Hammerel  $5,000    8.50%  9/21/2017  9/21/2024   (1)   (2)   (5)
Bret Renaud  $5,000    8.50%  10/14/2017  10/14/2024   (1)   (2)   (5)
Elatam Group Ltd  $67,000    7.50%  8/24/2021  5/31/2028   (1)   (2)   (6)
James Hardy  $7,000    7.50%  8/24/2021  5/31/2028   (1)   (2)   (6)
Acepac Holdings  $1,000,000    7.50%  8/24/2021  5/31/2028   (1)   (4)   (6)
Rick Ward  $15,000    7.50%  8/24/2021  5/31/2028   (1)   (2)   (6)
Robert & Joan Sweetman  $10,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Michael Swenson  $10,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Connie Sun  $3,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Elizabeth Enoch  $10,000    8.00%  8/1/2018  7/1/2025   (1)   (2)   (6)
William C. Stanton and Carol Stanton  $3,000    8.00%  7/1/2018  7/1/2025   (1)   (2)   (6)
Total  $3,135,000                           

 

  (1) All notes above are secured by the following collateral: all the assets of Idaho CuMo except for the following patented lode mining claims located in Section 13, Township 8 North, Range 5 East, Boise Meridian, Boise County, Idaho, as depicted on Mineral Survey 1706: (i) Blackbird, (ii) Red Flag, (iii) Enterprise, (iv) Enterprise Fraction, (v) Commonwealth, (vi) Baby Mine. Each Note will rank pari passu with all other Notes.
  (2) Financial investment by accredited investor.
  (3) Issued in exchange for 20 unpatented mining claims located approximately 10 miles northeast of Pioneerville, Idaho.
  (4) Issued to settle litigation between MultiMetal Development Ltd. (former parent company of Idaho Copper Corp) and Acepac Holdings.
  (5) Interest capitalized; accrual dates 6/30 and 12/31.
  (6) Interest paid in cash on 6/30 and 12/31.
  (7) On September 25, 2023, these notes were extended from February 15, 2024, to February 15, 2025. The extension was analyzed for modification versus extinguishment and was determined to be a modification.
v3.24.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Oct. 31, 2024
Equity [Abstract]  
SCHEDULE OF ESTIMATED FAIR VALUE OF WARRANTS

 

Stock price  $ 0.070.20 
Exercise price  $0.24 
Expected volatility   521 -1,042%
Expected term (years)   3 
Risk free rate   4.054.45%
Dividends   0%
v3.24.3
COMMITMENTS AND CONTINGENCIES (Tables)
9 Months Ended
Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
SCHEDULE OF RIGHT OF USE ASSET AND LIABILITY

Initially, the Company measure the right of use asset and liability associated with its office lease using the following inputs:

 

Remaining lease term (in years)   1.08 
Discount rate   12%
SCHEDULE OF ESTIMATED FUTURE MINIMUM LEASE PAYMENTS

The Company records rent on straight-line basis over the terms of the underlying lease. Estimated future minimum lease payments under the lease are as follows:

 

Year Ending January 31,  Amount 
2025  $43,200 
Total remaining lease payments   43,200 
Less: imputed interest   22,357 
Present value of remaining lease payments  $20,843 
v3.24.3
INCOME TAXES (Tables)
9 Months Ended
Oct. 31, 2024
Income Tax Disclosure [Abstract]  
SCHEDULE OF TAX EXPENSE FOR FEDERAL INCOME TAX PURPOSES

 

   October 31,   January 31, 
   2024   2024 
Tax expense (benefit) at the statutory rate  $(452,604)  $(285,980)
State income taxes, net of federal income tax benefit   (107,763)   (68,090)
Change in valuation allowance   560,367    354,070 
Total  $-   $- 
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

The tax effect of significant components of the Company’s deferred tax assets and liabilities at October 31, 2024 and January 31, 2024 are as follows:

 

   October 31, 2024   January 31, 2024 
Deferred tax assets:          
Net operating loss carryforward  $1,312,283   $751,916 
Timing differences   -    - 
Total gross deferred tax assets   1,312,283    751,916 
Less: Deferred tax asset valuation allowance   (1,312,283)   (751,916)
Total net deferred taxes  $-   $- 
v3.24.3
NATURE OF OPERATIONS (Details Narrative) - $ / shares
Jan. 23, 2023
Feb. 03, 2022
Purchase Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Buyer purchased common stock shares   16,644,820
Share Exchange Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Number of shares issued 182,240,000  
Common stock, par value $ 0.001  
v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Oct. 31, 2024
Jul. 31, 2024
Apr. 30, 2024
Oct. 31, 2023
Jul. 31, 2023
Apr. 30, 2023
Oct. 31, 2024
Oct. 31, 2023
Jan. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Cash $ 18,731           $ 18,731   $ 30,146
Incurred net losses 2,352,581 $ 1,035,981 $ 1,044,266 $ 580,459 $ 587,531 $ 575,001 4,432,829 $ 1,742,990  
Working capital deficit 1,497,605           1,497,605    
FDIC amount 250,000           250,000    
Cash insurance limits 0           0    
Convertible notes payable 405,305           405,305    
Accumulated deficit (36,438,438)           (36,438,438)   $ (31,600,305)
Accounting Standards Update 2020-06 [Member]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Accumulated deficit $ 405,305           $ 405,305    
Convertible Debt Securities [Member]                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Weighted average number of shares outstanding, diluted             53,214,479    
v3.24.3
RECLAMATION BONDS AND PROVISIONS (Details Narrative) - USD ($)
Apr. 05, 2024
Dec. 31, 2016
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Debt instrument, face value $ 201,200  
Surety Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Debt instrument, annual payment   $ 8,340
Deposit   100,000
Debt instrument, face value   $ 278,000
v3.24.3
SCHEDULE OF CONVERTIBLE SECURED NOTES PAYABLE (Details) - USD ($)
12 Months Ended
Jan. 31, 2024
Oct. 31, 2024
Apr. 05, 2024
Short-Term Debt [Line Items]      
Balance   $ 405,305  
Conversion Price     $ 0.23
Convertible Notes Payable [Member]      
Short-Term Debt [Line Items]      
Balance $ 1,100,200 $ 0 $ 1,099,200
Conversion Shares 9,854,783    
Warrant Shares 10,073,479    
Convertible Notes Payable [Member] | The Jeffrey V. and Karin R. Hembrock Revocable Trust [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 100,000    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 1,000,000    
Warrant Shares [1] 1,000,000    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | The Gaitonde Living Trust, Girish Gaitonde Trustee [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 100,000    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 1,000,000    
Warrant Shares [1] 1,000,000    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | PV Partners, LP [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 75,000    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 750,000    
Warrant Shares [1] 750,000    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | Steven Rudofsky [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 125,000    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 1,250,000    
Warrant Shares [1] 1,250,000    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | Feehan Partners. LP [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 87,334    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 873,340    
Warrant Shares [1] 873,340    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | Corey Redfield [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 50,000    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 500,000    
Warrant Shares [1] 500,000    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | Shaun Dykes [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 30,000    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 300,000    
Warrant Shares [1] 300,000    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | Patricia Czerniej [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 30,000    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 300,000    
Warrant Shares [1] 300,000    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | James Dykes [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 30,000    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 300,000    
Warrant Shares [1] 300,000    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | Jason Czerniej [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 30,000    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 300,000    
Warrant Shares [1] 300,000    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | Louise Dykes [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 30,000    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 300,000    
Warrant Shares [1] 300,000    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | Andrew Brodkey [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 98,000    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 980,000    
Warrant Shares [1] 980,000    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | Feehan Partners, LP [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 112,666    
Issue Date [1] Jan. 23, 2023    
Maturity Date [1] Jul. 23, 2025    
Conversion Price [1] $ 0.10    
Conversion Shares [1] 1,126,660    
Warrant Shares [1] 1,126,660    
Exercise Price [1] $ 0.15    
Warrant Expiration [1] Jan. 23, 2028    
Convertible Notes Payable [Member] | Gil Atzmon [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 102,200    
Issue Date [1] May 08, 2023    
Maturity Date [1] Nov. 08, 2025    
Conversion Price [1] $ 0.23    
Conversion Shares [1] 440,000    
Warrant Shares [1] 550,000    
Exercise Price [1] $ 0.23    
Warrant Expiration [1] May 08, 2026    
Convertible Notes Payable [Member] | Jon Powell [Member]      
Short-Term Debt [Line Items]      
Balance [1] $ 100,000    
Issue Date [1] May 08, 2023    
Maturity Date [1] Nov. 08, 2025    
Conversion Price [1] $ 0.23    
Conversion Shares [1] 434,783    
Warrant Shares [1] 543,479    
Exercise Price [1] $ 0.23    
Warrant Expiration [1] May 08, 2026    
[1] The replacement notes and new warrants are secured by mining claims and rights of the CuMo Project.
v3.24.3
CONVERTIBLE NOTES (Details Narrative) - USD ($)
Apr. 05, 2024
Oct. 31, 2024
Jan. 31, 2024
Short-Term Debt [Line Items]      
Convertible secured notes payable   $ 405,305  
Convertible Notes Payable [Member]      
Short-Term Debt [Line Items]      
Convertible secured notes payable $ 1,099,200 $ 0 $ 1,100,200
Notes payable     $ 476,201
Issuance of common shares 9,854,783    
v3.24.3
SCHEDULE OF BOND LIABILITIES (Details)
9 Months Ended
Oct. 31, 2024
USD ($)
Principal Amount $ 3,135,000
Barry Swenson [Member]  
Principal Amount $ 500,000 [1],[2],[3]
Interest Rate 8.50% [1],[2],[3]
Note Date Dec. 31, 2017 [1],[2],[3]
Maturity Date Dec. 31, 2025 [1],[2],[3]
Don H. Adair or Joanne Adair [Member]  
Principal Amount $ 125,000 [1],[4],[5],[6]
Interest Rate 8.50% [1],[4],[5],[6]
Note Date Feb. 15, 2017 [1],[4],[5],[6]
Maturity Date Feb. 15, 2024 [1],[4],[5],[6]
Joseph Swinford or Danielle Swinford [Member]  
Principal Amount $ 50,000 [1],[4],[5],[6]
Interest Rate 8.50% [1],[4],[5],[6]
Note Date Feb. 15, 2017 [1],[4],[5],[6]
Maturity Date Feb. 15, 2024 [1],[4],[5],[6]
Brandon Swain or Sierra Swain [Member]  
Principal Amount $ 50,000 [1],[4],[5],[6]
Interest Rate 8.50% [1],[4],[5],[6]
Note Date Feb. 15, 2017 [1],[4],[5],[6]
Maturity Date Feb. 15, 2024 [1],[4],[5],[6]
Scott Collins or Kendra Collins [Member]  
Principal Amount $ 12,500 [1],[4],[5],[6]
Interest Rate 8.50% [1],[4],[5],[6]
Note Date Feb. 15, 2017 [1],[4],[5],[6]
Maturity Date Feb. 15, 2024 [1],[4],[5],[6]
Carl Collins or Ellen Collins [Member]  
Principal Amount $ 12,500 [1],[4],[5]
Interest Rate 8.50% [1],[4],[5]
Note Date Feb. 15, 2017 [1],[4],[5]
Maturity Date Feb. 15, 2024 [1],[4],[5]
Jim Hammerel [Member]  
Principal Amount $ 5,000 [1],[2],[3]
Interest Rate 8.50% [1],[2],[3]
Note Date Sep. 21, 2017 [1],[2],[3]
Maturity Date Sep. 21, 2024 [1],[2],[3]
Bret Renaud [Member]  
Principal Amount $ 5,000 [1],[2],[3]
Interest Rate 8.50% [1],[2],[3]
Note Date Oct. 14, 2017 [1],[2],[3]
Maturity Date Oct. 14, 2024 [1],[2],[3]
James Hardy [Member]  
Principal Amount $ 7,000 [1],[2],[4]
Interest Rate 7.50% [1],[2],[4]
Note Date Aug. 24, 2021 [1],[2],[4]
Maturity Date May 31, 2028 [1],[2],[4]
Rick Ward [Member]  
Principal Amount $ 15,000 [1],[2],[4]
Interest Rate 7.50% [1],[2],[4]
Note Date Aug. 24, 2021 [1],[2],[4]
Maturity Date May 31, 2028 [1],[2],[4]
Robert & Joan Sweetman [Member]  
Principal Amount $ 10,000 [1],[2],[4]
Interest Rate 8.00% [1],[2],[4]
Note Date Jul. 01, 2018 [1],[2],[4]
Maturity Date Jul. 01, 2025 [1],[2],[4]
Michael Swenson [Member]  
Principal Amount $ 10,000 [1],[2],[4]
Interest Rate 8.00% [1],[2],[4]
Note Date Jul. 01, 2018 [1],[2],[4]
Maturity Date Jul. 01, 2025 [1],[2],[4]
Connie Sun [Member]  
Principal Amount $ 3,000 [1],[2],[4]
Interest Rate 8.00% [1],[2],[4]
Note Date Jul. 01, 2018 [1],[2],[4]
Maturity Date Jul. 01, 2025 [1],[2],[4]
Elizabeth Enoch [Member]  
Principal Amount $ 10,000 [1],[2],[4]
Interest Rate 8.00% [1],[2],[4]
Note Date Aug. 01, 2018 [1],[2],[4]
Maturity Date Jul. 01, 2025 [1],[2],[4]
William C. Stanton and Carol Stanton [Member]  
Principal Amount $ 3,000 [1],[2],[4]
Interest Rate 8.00% [1],[2],[4]
Note Date Jul. 01, 2018 [1],[2],[4]
Maturity Date Jul. 01, 2025 [1],[2],[4]
Yin Yin Silver Limited [Member]  
Principal Amount $ 500,000 [1],[2],[3]
Interest Rate 8.50% [1],[2],[3]
Note Date Aug. 04, 2015 [1],[2],[3]
Maturity Date Aug. 04, 2025 [1],[2],[3]
Yin Yin Silver Limited One [Member]  
Principal Amount $ 500,000 [1],[2],[3]
Interest Rate 8.50% [1],[2],[3]
Note Date Oct. 28, 2016 [1],[2],[3]
Maturity Date Oct. 28, 2026 [1],[2],[3]
Yin Yin Silver Limited Two [Member]  
Principal Amount $ 250,000 [1],[2],[3]
Interest Rate 8.50% [1],[2],[3]
Note Date Dec. 27, 2017 [1],[2],[3]
Maturity Date Dec. 27, 2024 [1],[2],[3]
Elatam Group Ltd [Member]  
Principal Amount $ 67,000 [1],[2],[4]
Interest Rate 7.50% [1],[2],[4]
Note Date Aug. 24, 2021 [1],[2],[4]
Maturity Date May 31, 2028 [1],[2],[4]
Acepac Holdings [Member]  
Principal Amount $ 1,000,000 [1],[4],[7]
Interest Rate 7.50% [1],[4],[7]
Note Date Aug. 24, 2021 [1],[4],[7]
Maturity Date May 31, 2028 [1],[4],[7]
[1] All notes above are secured by the following collateral: all the assets of Idaho CuMo except for the following patented lode mining claims located in Section 13, Township 8 North, Range 5 East, Boise Meridian, Boise County, Idaho, as depicted on Mineral Survey 1706: (i) Blackbird, (ii) Red Flag, (iii) Enterprise, (iv) Enterprise Fraction, (v) Commonwealth, (vi) Baby Mine. Each Note will rank pari passu with all other Notes.
[2] Financial investment by accredited investor.
[3] Interest capitalized; accrual dates 6/30 and 12/31.
[4] Interest paid in cash on 6/30 and 12/31.
[5] Issued in exchange for 20 unpatented mining claims located approximately 10 miles northeast of Pioneerville, Idaho.
[6] On September 25, 2023, these notes were extended from February 15, 2024, to February 15, 2025. The extension was analyzed for modification versus extinguishment and was determined to be a modification.
[7] Issued to settle litigation between MultiMetal Development Ltd. (former parent company of Idaho Copper Corp) and Acepac Holdings.
v3.24.3
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 25, 2024
Aug. 02, 2024
May 01, 2024
Apr. 08, 2024
Apr. 06, 2024
Apr. 05, 2024
Apr. 04, 2024
Apr. 03, 2024
Apr. 30, 2024
Oct. 31, 2023
Apr. 30, 2023
Oct. 31, 2024
Jan. 31, 2024
Jan. 23, 2023
Related Party Transaction [Line Items]                            
Convertible notes payable                       $ 405,305    
Converted notes payable into shares of common stock issued           880,000                
Vested stock options, shares                       6,566,000 22,646,000  
Vested stock options per share               $ 0.125            
Stock options exercised               3,385,000            
Issued stock incentives value                     $ 140,739      
Common Stock [Member]                            
Related Party Transaction [Line Items]                            
Stock options exercised               11,055,000            
Number of shares conversion         753,750       12,848,116 3,844,073        
Issued stock incentives                     879,628      
Issued stock incentives value                     $ 879      
Warrant [Member]                            
Related Party Transaction [Line Items]                            
Cashless conversion         1,200,000                  
Steven Rudofsky [Member]                            
Related Party Transaction [Line Items]                            
Accrued compensation   $ 31,250 $ 31,250                      
Convertible notes payable           $ 125,000                
Converted notes payable into shares of common stock issued   125,000 195,313     1,666,667                
Cashless conversion               5,360,000            
Issued stock incentives 125,000                          
Issued stock incentives value $ 27,500                          
Steven Rudofsky [Member] | Common Stock [Member]                            
Related Party Transaction [Line Items]                            
Number of shares conversion       1,041,667                    
Steven Rudofsky [Member] | Warrant [Member]                            
Related Party Transaction [Line Items]                            
Cashless conversion       1,666,667                    
Steven Rudofsky [Member] | Convertible Notes Payable [Member]                            
Related Party Transaction [Line Items]                            
Convertible notes payable                           $ 125,000
Feehan Partners [Member]                            
Related Party Transaction [Line Items]                            
Convertible notes payable           $ 200,000                
Converted notes payable into shares of common stock issued           2,666,666                
Feehan Partners [Member] | Common Stock [Member]                            
Related Party Transaction [Line Items]                            
Number of shares conversion             1,666,666              
Feehan Partners [Member] | Warrant [Member]                            
Related Party Transaction [Line Items]                            
Cashless conversion             2,666,666              
Feehan Partners [Member] | Convertible Notes Payable [Member]                            
Related Party Transaction [Line Items]                            
Convertible notes payable                           87,334
Feehan Partners [Member] | Convertible Notes Payable One [Member]                            
Related Party Transaction [Line Items]                            
Convertible notes payable                           112,666
Andrew Brodkey [Member]                            
Related Party Transaction [Line Items]                            
Accrued compensation   $ 42,500 $ 17,500                      
Convertible notes payable           $ 98,000               98,000
Converted notes payable into shares of common stock issued   170,000 109,375     1,306,667                
Cashless conversion               5,360,000            
Issued stock incentives 2,570,000                          
Issued stock incentives value $ 565,400                          
Related party payables                       $ 54,000    
Andrew Brodkey [Member] | Common Stock [Member]                            
Related Party Transaction [Line Items]                            
Number of shares conversion             816,666              
Andrew Brodkey [Member] | Warrant [Member]                            
Related Party Transaction [Line Items]                            
Cashless conversion             1,306,667              
Shaun Dykes [Member]                            
Related Party Transaction [Line Items]                            
Convertible notes payable           $ 30,000               $ 150,000
Converted notes payable into shares of common stock issued           400,000                
Cashless conversion               5,360,000            
Shaun Dykes [Member] | Common Stock [Member]                            
Related Party Transaction [Line Items]                            
Number of shares conversion         251,250                  
Shaun Dykes [Member] | Warrant [Member]                            
Related Party Transaction [Line Items]                            
Cashless conversion         400,000                  
Robert Scannell [Member]                            
Related Party Transaction [Line Items]                            
Accrued compensation   $ 87,500 $ 62,500                      
Converted notes payable into shares of common stock issued   350,000 390,625                      
Vested stock options, shares               5,360,000            
Cashless conversion               5,360,000            
Issued stock incentives 2,500,000                          
Issued stock incentives value $ 550,000                          
Officer [Member]                            
Related Party Transaction [Line Items]                            
Accrued compensation                       388,971    
Compensation to officers                       $ 858,500    
v3.24.3
SCHEDULE OF ESTIMATED FAIR VALUE OF WARRANTS (Details) - Warrant [Member]
Oct. 31, 2024
$ / shares
Measurement Input, Share Price [Member] | Minimum [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Stock price $ 0.07
Measurement Input, Share Price [Member] | Maximum [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Stock price 0.20
Measurement Input, Exercise Price [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Exercise price $ 0.24
Measurement Input, Price Volatility [Member] | Minimum [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Warrants measurement input 521
Measurement Input, Price Volatility [Member] | Maximum [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Warrants measurement input 1,042
Measurement Input, Expected Term [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Expected term (years) 3 years
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Warrants measurement input 4.05
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Warrants measurement input 4.45
Measurement Input, Expected Dividend Rate [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Warrants measurement input 0
v3.24.3
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Nov. 05, 2024
Sep. 25, 2024
Aug. 02, 2024
Jul. 11, 2024
May 31, 2024
May 01, 2024
Apr. 08, 2024
Apr. 06, 2024
Apr. 05, 2024
Apr. 04, 2024
Apr. 03, 2024
Jan. 12, 2024
Jan. 23, 2023
Oct. 31, 2024
Jul. 31, 2024
Apr. 30, 2024
Oct. 31, 2023
Oct. 31, 2024
Oct. 31, 2023
Jan. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Preferred stock, shares authorized                           10,000,000       10,000,000   10,000,000
Preferred stock, par value                           $ 0.001       $ 0.001   $ 0.001
Common stock, par value                           $ 0.001       $ 0.001   $ 0.001
Stock issued during period, new issues                           $ 12,000 $ 320,084 $ 1,753,300        
Preferred stock, shares outstanding                           186.67       186.67   23
Common stock, shares authorized                           500,000,000       500,000,000   500,000,000
Converted notes payable into shares of common stock issued                 880,000                      
Common stock, shares issued                           256,942,937       256,942,937   214,647,732
Common stock, shares issuable                           256,942,937       256,942,937    
Common Stock, Shares, Outstanding                           256,942,937       256,942,937   214,647,732
Options vested, shares                                   6,566,000   22,646,000
Exercise price                         $ 0.125              
Expiration date                         Dec. 31, 2027              
Stock based compensation expense                                   $ 189,248    
Options vest value                           $ 568,000       $ 568,000    
Option description                                   The remaining vesting milestones required to be met are (1) obtaining an updated PEA, (2) an uplist of the Company’s common stock to a national exchange and (3) the successful raising of $5 million or more in new capital. Each of these milestones vest an additional 20% of the options upon being met and were estimated to have a 50% probability of being met as of January 31, 2024. Management reviews the estimate of meeting each probability as well as the related timing at each reporting period.    
Stock based compensation                           $ 1,704,024     $ 2,258,080 $ 140,739  
January 23, 2023 [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Warrant per share                           $ 0.15       $ 0.15    
Warrants outstanding                           2,614,783       2,614,783    
May 8, 2023 [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Warrant per share                           $ 0.23       $ 0.23    
Warrants outstanding                           1,093,479       1,093,479    
Officer [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of shares issued         1,041,667                              
Accrued compensation                                   $ 388,971    
Non-Officer [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of shares issued                                   1,039,096    
Officers Directors and Employees [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Options issued                         56,615,000              
Steven Rudofsky [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Stock issued during period, new issues   $ 27,500                                    
Number of shares issued   125,000                 3,685,000                  
Accrued compensation     $ 31,250     $ 31,250                            
Converted notes payable into shares of common stock issued     125,000     195,313     1,666,667                      
Cashless conversion                     5,360,000                  
Andrew Brodkey [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Stock issued during period, new issues   $ 565,400                                    
Number of shares issued   2,570,000                 3,685,000                  
Accrued compensation     $ 42,500     $ 17,500                            
Converted notes payable into shares of common stock issued     170,000     109,375     1,306,667                      
Cashless conversion                     5,360,000                  
Robert Scannell [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Stock issued during period, new issues   $ 550,000                                    
Number of shares issued   2,500,000                 3,685,000                  
Accrued compensation     $ 87,500     $ 62,500                            
Converted notes payable into shares of common stock issued     350,000     390,625                            
Options vested, shares                     5,360,000                  
Cashless conversion                     5,360,000                  
Other Employees and Non-employees [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Converted compensation, shares     439,000                                  
Converted compensation     $ 574,750                                  
Employees and Non-employees [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Stock issued during period, new issues   $ 82,500                                    
Number of shares issued   375,000                                    
Shaun Dykes [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of shares issued                     3,685,000                  
Converted notes payable into shares of common stock issued                 400,000                      
Cashless conversion                     5,360,000                  
Feehan Partners [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Converted notes payable into shares of common stock issued                 2,666,666                      
Common Stock [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Stock issued during period, new issues                                  
Number of shares issued       9,283,333                                
Number of shares conversion               753,750               12,848,116 3,844,073      
Common Stock [Member] | Steven Rudofsky [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of shares issued 397,727                                      
Number of shares conversion             1,041,667                          
Common Stock [Member] | Andrew Brodkey [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of shares issued 193,182                                      
Number of shares conversion                   816,666                    
Common Stock [Member] | Shaun Dykes [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of shares conversion               251,250                        
Common Stock [Member] | Feehan Partners [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Number of shares conversion                   1,666,666                    
Warrant [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Stock issued during period, new issues                                   $ 156,746    
Number of shares issued                                   1,125,000    
Warrants shares       11,604,167                                
Cashless conversion               1,200,000                        
Warrant [Member] | Steven Rudofsky [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Cashless conversion             1,666,667                          
Warrant [Member] | Andrew Brodkey [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Cashless conversion                   1,306,667                    
Warrant [Member] | Shaun Dykes [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Cashless conversion               400,000                        
Warrant [Member] | Feehan Partners [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Cashless conversion                   2,666,666                    
Subscription Agreement [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Preferred stock, par value                           $ 0.001       $ 0.001    
Preferred units description                       On January 12, 2024, we entered into Unit Subscription Purchase Agreements (“Subscription Agreements”) with purchasers for an aggregate of 23 (“Units”) at a price of $12,000 per Unit. Each Unit comprised of one (1) share of Series A Convertible Non-Voting Preferred Stock, $0.001 par value per share (the “Series A Preferred Stock”), and (ii) 62,500 common stock purchase warrants (the “Warrants”).                
Common stock, par value                       $ 0.001   $ 0.001       $ 0.001    
Warrant term                       3 years   3 years       3 years    
Warrant per share                           $ 0.24       $ 0.24    
Private placement offering per share                           $ 12,000       $ 12,000    
Private placement offering                                   $ 1,964,000    
Warrants outstanding                           62,500       62,500    
Warrants shares                           50,000       50,000    
Subscription Agreement [Member] | Common Stock [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Converted compensation, shares                       50,000                
Subscription Agreement [Member] | Warrant [Member]                                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                                        
Warrant per share                       $ 0.24                
v3.24.3
SCHEDULE OF RIGHT OF USE ASSET AND LIABILITY (Details)
Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Remaining lease term (in years) 1 year 29 days
Discount rate 12.00%
v3.24.3
SCHEDULE OF ESTIMATED FUTURE MINIMUM LEASE PAYMENTS (Details)
Oct. 31, 2024
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2025 $ 43,200
Total remaining lease payments 43,200
Less: imputed interest (22,357)
Present value of remaining lease payments $ 20,843
v3.24.3
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
9 Months Ended
Apr. 01, 2024
Mar. 05, 2024
Feb. 01, 2025
Oct. 31, 2024
Oct. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Initial term       3 years  
Payment for lease   $ 100,000      
Lease term       13 months  
Rent expense       $ 143,085 $ 21,000
LongTerm Lease Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Initial term 3 years        
Operating lease renewal term 3 years        
Lease payment base rent January 1, 2026       3,600  
Lease payment base rent January 1, 2027       3,700  
Lease payment base rent January 1, 2028       3,800  
Lease payment base rent January 1, 2028 there after       $ 3,900  
LongTerm Lease Agreement [Member] | Forecast [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Payment for lease     $ 6,000    
v3.24.3
SCHEDULE OF TAX EXPENSE FOR FEDERAL INCOME TAX PURPOSES (Details) - USD ($)
9 Months Ended 12 Months Ended
Oct. 31, 2024
Jan. 31, 2024
Income Tax Disclosure [Abstract]    
Tax expense (benefit) at the statutory rate $ (452,604) $ (285,980)
State income taxes, net of federal income tax benefit (107,763) (68,090)
Change in valuation allowance 560,367 354,070
Total
v3.24.3
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Oct. 31, 2024
Jan. 31, 2024
Deferred tax assets:    
Net operating loss carryforward $ 1,312,283 $ 751,916
Timing differences
Total gross deferred tax assets 1,312,283 751,916
Less: Deferred tax asset valuation allowance (1,312,283) (751,916)
Total net deferred taxes
v3.24.3
INCOME TAXES (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended
Oct. 31, 2024
Jan. 31, 2024
Income Tax Disclosure [Abstract]    
Net operating loss carry forwards $ 1,312,283 $ 751,916
Federal tax, rate 21.00% 21.00%
State tax, rate 5.00% 5.00%
Valuation allowance description Company, the net deferred tax assets for 2023 were fully offset by a 100% valuation allowance.  
Deferred tax asset valuation allowance $ 1,312,283 $ 751,916
v3.24.3
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Nov. 05, 2024
Sep. 25, 2024
Aug. 02, 2024
Jul. 11, 2024
May 01, 2024
Apr. 08, 2024
Apr. 06, 2024
Apr. 05, 2024
Apr. 04, 2024
Apr. 03, 2024
Jan. 23, 2023
Dec. 15, 2022
Oct. 31, 2024
Jul. 31, 2024
Apr. 30, 2024
Oct. 31, 2023
Oct. 31, 2024
Nov. 04, 2024
Jan. 31, 2024
Subsequent Event [Line Items]                                      
Principal amount               $ 201,200                      
Stock issued during period, value new issues                         $ 12,000 $ 320,084 $ 1,753,300        
Preferred stock, par value                         $ 0.001       $ 0.001   $ 0.001
Sold private placement shares                       4,333,333              
Conversion of shares, principal and accrued interest               880,000                      
Conversion price               $ 0.23                      
Series A Convertible Non Voting Preferred Stock [Member] | Private Placement [Member]                                      
Subsequent Event [Line Items]                                      
Conversion shares       185.66                              
Preferred stock, par value       $ 0.001                              
Placement Agent [Member]                                      
Subsequent Event [Line Items]                                      
Sale of preferred stock, shares       813,333                              
Former Shareholders [Member]                                      
Subsequent Event [Line Items]                                      
Exchange shares                     66,794,143                
Consultants [Member]                                      
Subsequent Event [Line Items]                                      
Sale of preferred stock, shares       418,333                              
Common Stock [Member]                                      
Subsequent Event [Line Items]                                      
Sale of preferred stock, shares       9,283,333                              
Stock issued during period, value new issues                                
Resell up shares       94,126,642                              
Conversion shares             753,750               12,848,116 3,844,073      
Warrant [Member]                                      
Subsequent Event [Line Items]                                      
Sale of preferred stock, shares                                 1,125,000    
Converted compensation shares             1,200,000                        
Stock issued during period, value new issues                                 $ 156,746    
Exercise of warrants sold shares       11,604,167                              
Andrew Brodkey [Member]                                      
Subsequent Event [Line Items]                                      
Accrued compensation     $ 42,500   $ 17,500                            
Sale of preferred stock, shares   2,570,000               3,685,000                  
Converted compensation shares                   5,360,000                  
Stock issued during period, value new issues   $ 565,400                                  
Conversion of shares, principal and accrued interest     170,000   109,375     1,306,667                      
Andrew Brodkey [Member] | Common Stock [Member]                                      
Subsequent Event [Line Items]                                      
Sale of preferred stock, shares 193,182                                    
Conversion shares                 816,666                    
Andrew Brodkey [Member] | Warrant [Member]                                      
Subsequent Event [Line Items]                                      
Converted compensation shares                 1,306,667                    
Steven Rudofsky [Member]                                      
Subsequent Event [Line Items]                                      
Accrued compensation     $ 31,250   $ 31,250                            
Sale of preferred stock, shares   125,000               3,685,000                  
Converted compensation shares                   5,360,000                  
Stock issued during period, value new issues   $ 27,500                                  
Conversion of shares, principal and accrued interest     125,000   195,313     1,666,667                      
Steven Rudofsky [Member] | Common Stock [Member]                                      
Subsequent Event [Line Items]                                      
Sale of preferred stock, shares 397,727                                    
Conversion shares           1,041,667                          
Steven Rudofsky [Member] | Warrant [Member]                                      
Subsequent Event [Line Items]                                      
Converted compensation shares           1,666,667                          
Subsequent Event [Member]                                      
Subsequent Event [Line Items]                                      
Accrues interest                                   10.00%  
Subsequent Event [Member] | Steven Rudofsky [Member]                                      
Subsequent Event [Line Items]                                      
Warrants exercised 500,000                                    
Exercise Price $ 0.15                                    
Subsequent Event [Member] | Common Stock [Member] | Other Employees and Non-employees [Member]                                      
Subsequent Event [Line Items]                                      
Converted compensation value $ 67,500                                    
Converted compensation shares 306,818                                    
Subsequent Event [Member] | Common Stock [Member] | Steven Rudofsky [Member]                                      
Subsequent Event [Line Items]                                      
Sale of preferred stock, shares 500,000                                    
Stock issued during period, value new issues $ 75,000                                    
Subsequent Event [Member] | Andrew Brodkey [Member]                                      
Subsequent Event [Line Items]                                      
Accrued compensation 42,500                                    
Subsequent Event [Member] | Steven Rudofsky [Member]                                      
Subsequent Event [Line Items]                                      
Accrued compensation $ 87,500                                    
Secured Promissory Note [Member] | Subsequent Event [Member]                                      
Subsequent Event [Line Items]                                      
Principal amount                                   $ 25,000  

Idaho Copper (PK) (USOTC:COPR)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Idaho Copper (PK).
Idaho Copper (PK) (USOTC:COPR)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Idaho Copper (PK).